<!DOCTYPE article PUBLIC "-//NLM//DTD Journal Archiving and Interchange DTD v3.0 20080202//EN" "archivearticle3.dtd"> 
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" article-type="review-article"><?properties open_access?><?DTDIdentifier.IdentifierValue -//Springer-Verlag//DTD A++ V2.4//EN?><?DTDIdentifier.IdentifierType public?><?SourceDTD.DTDName A++V2.4.dtd?><?SourceDTD.Version 2.4?><?ConverterInfo.XSLTName springer2nlmx2.xsl?><?ConverterInfo.Version 2?><front><journal-meta><journal-id journal-id-type="nlm-ta">Cell Mol Life Sci</journal-id><journal-title-group><journal-title>Cellular and Molecular Life Sciences</journal-title></journal-title-group><issn pub-type="ppub">1420-682X</issn><issn pub-type="epub">1420-9071</issn><publisher><publisher-name>SP Birkh&#x000e4;user Verlag Basel</publisher-name><publisher-loc>Basel</publisher-loc></publisher></journal-meta><article-meta><article-id pub-id-type="pmcid">3101357</article-id><article-id pub-id-type="publisher-id">674</article-id><article-id pub-id-type="doi">10.1007/s00018-011-0674-x</article-id><article-categories><subj-group subj-group-type="heading"><subject>Review</subject></subj-group></article-categories><title-group><article-title>The possible functions of duplicated <italic>ets</italic> (GGAA) motifs located near transcription start sites of various human genes</article-title></title-group><contrib-group><contrib contrib-type="author" corresp="yes"><name><surname>Uchiumi</surname><given-names>Fumiaki</given-names></name><address><email>uchiumi@rs.noda.tus.ac.jp</email></address><xref ref-type="aff" rid="Aff1">1</xref><xref ref-type="aff" rid="Aff5">5</xref></contrib><contrib contrib-type="author"><name><surname>Miyazaki</surname><given-names>Satoru</given-names></name><xref ref-type="aff" rid="Aff2">2</xref></contrib><contrib contrib-type="author"><name><surname>Tanuma</surname><given-names>Sei-ichi</given-names></name><xref ref-type="aff" rid="Aff3">3</xref><xref ref-type="aff" rid="Aff4">4</xref><xref ref-type="aff" rid="Aff5">5</xref></contrib><aff id="Aff1"><label>1</label>Department of Gene Regulation, Faculty of Pharmaceutical Sciences, Tokyo University of Science, 2641 Yamazaki, Noda, Chiba 278-8510 Japan </aff><aff id="Aff2"><label>2</label>Department of Bioinformatics, Faculty of Pharmaceutical Sciences, Tokyo University of Science, 2641 Yamazaki, Noda, Chiba 278-8510 Japan </aff><aff id="Aff3"><label>3</label>Department of Biochemistry, Faculty of Pharmaceutical Sciences, Tokyo University of Science, 2641 Yamazaki, Noda, Chiba 278-8510 Japan </aff><aff id="Aff4"><label>4</label>Genome and Drug Research Center, Tokyo University of Science, 2641 Yamazaki, Noda, Chiba 278-8510 Japan </aff><aff id="Aff5"><label>5</label>Research Center for RNA Science, RIST, Tokyo University of Science, 2641 Yamazaki, Noda, Chiba 278-8510 Japan </aff></contrib-group><pub-date pub-type="epub"><day>3</day><month>4</month><year>2011</year></pub-date><pub-date pub-type="pmc-release"><day>3</day><month>4</month><year>2011</year></pub-date><pub-date pub-type="ppub"><month>6</month><year>2011</year></pub-date><volume>68</volume><issue>12</issue><fpage>2039</fpage><lpage>2051</lpage><history><date date-type="received"><day>16</day><month>11</month><year>2010</year></date><date date-type="rev-recd"><day>28</day><month>2</month><year>2011</year></date><date date-type="accepted"><day>17</day><month>3</month><year>2011</year></date></history><permissions><copyright-statement>&#x000a9; The Author(s) 2011</copyright-statement></permissions><abstract id="Abs1"><p>Transcription is one of the most fundamental nuclear functions and is an enzyme complex-mediated reaction that converts DNA sequences into mRNA. Analyzing DNA sequences of 5&#x02032;-flanking regions of several human genes that respond to 12-<italic>O</italic>-tetradecanoyl-phorbol-13-acetate (TPA) in HL-60 cells, we have identified that the <italic>ets</italic> (GGAA) motifs are duplicated, overlapped, or clustered within a 500-bp distance from the most 5&#x02032;-upstream region of the cDNA. Multiple protein factors including Ets family proteins are known to recognize and bind to the GGAA containing sequences. In addition, it has been reported that the <italic>ets</italic> motifs play important roles in regulation of various promoters. Here, we propose a molecular mechanism, defined by the presence of duplication and multiplication of the GGAA motifs, that is responsible for the initiation of transcription of several genes and for the recruitment of binding proteins to the transcription start site (TSS) of TATA-less promoters.</p></abstract><kwd-group><title>Keywords</title><kwd>Differentiation</kwd><kwd>Ets family proteins</kwd><kwd>GGAA motif</kwd><kwd>TATA-box</kwd><kwd>TATA-less promoters</kwd><kwd>TF-SEARCH</kwd><kwd>TSS</kwd></kwd-group><custom-meta-group><custom-meta><meta-name>issue-copyright-statement</meta-name><meta-value>&#x000a9; Springer Basel AG 2011</meta-value></custom-meta></custom-meta-group></article-meta></front><body><sec id="Sec1"><title>Introduction</title><p>A human promyelocytic cell line, HL-60, is frequently used to analyze cellular differentiation mechanisms [<xref ref-type="bibr" rid="CR1">1</xref>]. HL-60 cells differentiate into macrophage-like cells and granulocytic cells after treatments with 12-<italic>O</italic>-tetradecanoyl-phorbol-13-acetate (TPA) and all-<italic>trans</italic> retinoic acid (ATRA), respectively [<xref ref-type="bibr" rid="CR1">1</xref>&#x02013;<xref ref-type="bibr" rid="CR3">3</xref>]. In particular, it has been shown that the expression of a number of genes is augmented during differentiation induced by TPA [<xref ref-type="bibr" rid="CR4">4</xref>]. Recently, TPA was successfully administered to patients with myelocytic leukemia, leading to temporary remission [<xref ref-type="bibr" rid="CR5">5</xref>, <xref ref-type="bibr" rid="CR6">6</xref>]. This TPA-treatment is based on a concept that the growth and proliferation of lymphoma or cancer cells could be artificially suppressed if they are forced to differentiate into a non-growing state [<xref ref-type="bibr" rid="CR7">7</xref>]. However, TPA has been originally identified as a cancer-causing reagent (carcinogen) activating protein kinase C [<xref ref-type="bibr" rid="CR1">1</xref>]. Therefore, extreme care will be needed to administer the reagent in clinical situations.</p><p>It has been demonstrated that somatic cells could be converted into induced pluripotent stem (iPS) cells by introducing just four transcription factors, namely <italic>Oct4</italic>, <italic>Sox2</italic>, <italic>Klf4</italic>, and <italic>c</italic>-<italic>Myc</italic> expression vectors or their encoding proteins, into somatic cells [<xref ref-type="bibr" rid="CR8">8</xref>, <xref ref-type="bibr" rid="CR9">9</xref>]. The possibility to change the destiny of cells by introducing transcriptional factors prompted us to study transcription systems that control cellular differentiation. In order to establish a method to convert malignant cells to the non-growing differentiated state without using TPA, it will be important to determine and characterize molecular mechanisms in the transcriptional signal transduction systems that are induced by TPA. In other words, the changes in the TPA-induced transcriptional controlling system will provide useful information about which genes of transcription factors should be transfected into the malignant cells.</p><p>Previously, it has been demonstrated that the human <italic>PARG</italic> promoter is activated during the differentiation of HL-60 cells induced by TPA [<xref ref-type="bibr" rid="CR10">10</xref>]. Another example is the <italic>IGHMBP2</italic> promoter, whose cDNA was isolated by South-Western screening during a search for a gene encoding a binding factor to a 50-bp sequence of the MMTV LTR [<xref ref-type="bibr" rid="CR11">11</xref>]. Interestingly, there are no obvious TATA- or CCAAT-boxes around the transcription start sites (TSS), but the duplicated GGAA motifs are commonly contained in the region between the TSS and the 100-bp upstream of the human <italic>PARG</italic> and <italic>IGHMBP</italic> genes. In addition, mutation analyses showed that the duplicated GGAA motifs of both promoters play a primarily important role in promoter activity during the TPA-response [<xref ref-type="bibr" rid="CR10">10</xref>, <xref ref-type="bibr" rid="CR12">12</xref>]. Taken together, the duplicated (overlapped) GGAA motifs located very close to the TSS in the human <italic>PARG</italic> and <italic>IGHMBP2</italic> promoters are primarily required for the initiation of transcription during TPA responses. Studies on the transcriptional mechanisms regulated by the duplicated GGAA motifs and binding factors may provide a new strategy to artificially induce differentiation of leukemia or cancer cells by introducing specific gene expression- and suppression-vectors.</p></sec><sec id="Sec2"><title>Identification of the duplication of the GGAA motifs near the most 5&#x02032;-upstream regions of the TPA-inducible genes</title><p>It has been indicated that the GGAA motif is located in the promoter regions of some human genes encoding interleukin-2 receptor &#x003b2;-chain (IL-2R&#x003b2;), Ets-2, stromelysin 1, TCR&#x003b1; enhancer, TCR&#x003b2; enhancer, and NFAT-1 [<xref ref-type="bibr" rid="CR13">13</xref>]. Mutation of the GGAA motif abolished activity of the <italic>IL</italic>-<italic>2R&#x003b2;</italic> promoter during the PMA response in Jurkat cells. These observations, including ours that we reported in a recent paper [<xref ref-type="bibr" rid="CR10">10</xref>, <xref ref-type="bibr" rid="CR12">12</xref>], suggested a hypothesis that the GGAA motif might be an essential transcription regulatory element with a positive response to TPA-induced signals. By analyzing the activities of various promoters of human genes encoding DNA helicases, or repair-associated proteins, it has been shown that the duplicated GGAA motifs are located in the <italic>XPB</italic>, <italic>RTEL</italic>, and <italic>Rb1</italic> promoters [<xref ref-type="bibr" rid="CR14">14</xref>]. It has been reported that, during the macrophage-like differentiation of HL-60 cells, <italic>Rb1</italic> belongs to a group of TPA-inducible late genes [<xref ref-type="bibr" rid="CR4">4</xref>]. In addition, the expression of the <italic>PARG</italic> and the <italic>IGHMBP2</italic> genes shows a late responding profile, and the gene encoding the GA-binding transcription factor, &#x003b2; subunit 2, is classified into the early response group [<xref ref-type="bibr" rid="CR4">4</xref>, <xref ref-type="bibr" rid="CR10">10</xref>, <xref ref-type="bibr" rid="CR11">11</xref>]. Multiple GGAA motifs are contained in the promoter region of the human <italic>CD68</italic> gene that is widely regarded as a pan macrophage marker in immunohistochemistry studies, and its expression is regulated by Elf-1, PU.1, and IRF-4 [<xref ref-type="bibr" rid="CR15">15</xref>]. These observations suggested that duplications of the GGAA motifs are necessary for the TPA-late response or macrophage-like differentiated state of the cells. Therefore, DNA sequences of the 5&#x02032;-upstream regions of 19 late response genes were investigated and analyzed by a TF-SEARCH [<xref ref-type="bibr" rid="CR4">4</xref>, <xref ref-type="bibr" rid="CR14">14</xref>]. As summarized in Table&#x000a0;<xref rid="Tab1" ref-type="table">1</xref>, duplications of the GGAA motifs are found in eight TATA-less promoters, including the <italic>Rb1</italic>, <italic>CD31(PECAM1)</italic>, <italic>IL1R1</italic>, <italic>IL1R2</italic>, <italic>IL1RAPL2</italic>, <italic>S100A3</italic>, <italic>eIF3A</italic>, and <italic>ECM1</italic> promoters. The 5&#x02032;-flanking regions of the <italic>INHBA</italic> and <italic>S6 kinase</italic> genes contain clusters of GGAA motifs [<xref ref-type="bibr" rid="CR14">14</xref>]. Interestingly, promoter regions of the <italic>IL1R1</italic>, <italic>IL1R2</italic>, and <italic>IL1RAPL2</italic> genes, which encode the IL1 signal receptor or its associated proteins, have duplicated GGAA (TTCC) motifs (Table&#x000a0;<xref rid="Tab1" ref-type="table">1</xref>), suggesting that these genes are regulated by the IL1 signaling system. Although a single GGAA motif is located very close to the TSS of the <italic>PEA15</italic>, <italic>ANXA5</italic>, and <italic>RFC</italic>-<italic>1</italic> genes, another six promoters, including those of the <italic>LGALS3</italic>, <italic>PREP</italic>, <italic>CHST10</italic>, <italic>RFXAP</italic>, <italic>P2Y5</italic>, and <italic>KCNMA1</italic> genes, do not contain duplications of the GGAA motifs within the 300-bp from the most 5&#x02032;-upstream region of their cDNAs [<xref ref-type="bibr" rid="CR14">14</xref>]. Except for the <italic>P2Y5</italic> promoter, which contains TA-rich sequences with Oct-1 binding sites, these are comparatively rich in GC content with GC-boxes. Therefore, Sp1 or GC-box binding proteins might also play a role in the late response to TPA treatment in HL-60 cells.<table-wrap id="Tab1"><label>Table&#x000a0;1</label><caption><p>Duplication of the GGAA motifs in various human promoters</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="left">Genes</th><th align="left">Sequence</th></tr></thead><tbody><tr><td align="left"><italic>IL-1&#x003b2;</italic></td><td align="left">5&#x02032;-GAAGC<bold>TTCC</bold>ACCAATACTCTT<bold>TTCC</bold>CCT<bold>TTCC</bold>TTTAA-3&#x02032;</td></tr><tr><td align="left"><italic>CD31 (PECAM-1)</italic></td><td align="left">5&#x02032;-CCTCA<bold>GGAA</bold>GGCCGGTCAT<bold>TTCC</bold>TGAGG-3&#x02032;</td></tr><tr><td align="left"><italic>IL1R1</italic></td><td align="left">5&#x02032;-TGTTC<bold>TTCCTTCC</bold>CCAGG-3&#x02032;</td></tr><tr><td align="left"><italic>IL1R2</italic></td><td align="left">5&#x02032;-TCACA<bold>TTCCTTCC</bold>TACGC-3&#x02032;</td></tr><tr><td align="left"><italic>IL1RAPL2</italic></td><td align="left">5&#x02032;-CTCAT<bold>TTCC</bold>AGGCGCCC<bold>TTCC</bold>CTCTT-3&#x02032; (downstream of TSS)</td></tr><tr><td align="left"><italic>S100A3</italic></td><td align="left">5&#x02032;-AGCAA<bold>TTCC</bold>A<bold>GGAA</bold>GGGC<bold>TTCC</bold>CCTCC-3&#x02032;</td></tr><tr><td align="left"><italic>eIF3A</italic></td><td align="left">5&#x02032;-GCTCC<bold>TTCC</bold>T<bold>TTCC</bold>GTCTC-3&#x02032; (downstream of TSS)</td></tr><tr><td align="left"><italic>ECM1</italic></td><td align="left">5&#x02032;-GTGGC<bold>TTCC</bold>AGAGGAGGAGCAGCTGGGACTGAGTCATGGCA<bold>GGAA</bold>GCTGA-3&#x02032; (downstream of TSS)</td></tr><tr><td align="left"><italic>Rb1</italic></td><td align="left">5&#x02032;-CGGGC<bold>GGAA</bold>GTGACGTT<bold>TTCC</bold>CGCGG-3&#x02032;</td></tr><tr><td align="left"><italic>CD41 (ITGA2B)</italic></td><td align="left">5&#x02032;-AAGAC<bold>TTCC</bold>TGTGGA<bold>GGAA</bold>TCTGAAG<bold>GGAA</bold>GGAGG-3&#x02032;</td></tr><tr><td align="left"><italic>PDCD1</italic></td><td align="left">5&#x02032;-ACAGT<bold>TTCC</bold>C<bold>TTCC</bold>GCTCA-3&#x02032; (downstream of TSS)</td></tr><tr><td align="left"><italic>ISG15</italic></td><td align="left">5&#x02032;-CCTCG<bold>GGAA</bold>AG<bold>GGAA</bold>ACCGA-3&#x02032;</td></tr><tr><td align="left"><italic>CD40 (TNFRSF5)</italic></td><td align="left">5&#x02032;-TTGTG<bold>GGAA</bold>TGTTCTGG<bold>GGAA</bold>ACTCC-3&#x02032;</td></tr></tbody></table><table-wrap-foot><p>The 5&#x02032;-upstream regions (300&#x02013;500&#x000a0;bp upstream from TSS) of the human <italic>IL</italic>-<italic>1&#x003b2;-</italic> and TPA-inducible late responding genes [<xref ref-type="bibr" rid="CR4">4</xref>] were retrieved from the GRCh37 reference primary assembly sequence database and analyzed with the TF-SEARCH program (<ext-link ext-link-type="uri" xlink:href="http://www.cbrc.jp/research/db/TFSEARCH.html">http://www.cbrc.jp/research/db/TFSEARCH.html</ext-link>). Eight of the 20 &#x0201c;late responding&#x0201d; classified promoters contain duplicated or triplicated GGAA (TTCC) motifs [<xref ref-type="bibr" rid="CR4">4</xref>]. GGAA (TTCC) motifs in the IFN-inducible CD41, PDCD1, ISG15, and CD40 promoters are also shown</p></table-wrap-foot></table-wrap></p></sec><sec id="Sec3"><title>The duplicated GGAA motifs are located in the promoter regions of interferon-inducible genes, and interleukin, endocrine signal-associated genes</title><p>Multiple GGAA motifs are found in the promoter region of the human (Table&#x000a0;<xref rid="Tab1" ref-type="table">1</xref>) and the mouse <italic>ITGA2B</italic> genes encoding the megakaryocyte marker, CD41, that regulates cell adhesion and platelet aggregation [<xref ref-type="bibr" rid="CR16">16</xref>, <xref ref-type="bibr" rid="CR17">17</xref>]. It has been indicated that the MAP kinase signaling pathway and transcription factors such as Elk-1 and Ets play important roles in megakaryocytic differentiation [<xref ref-type="bibr" rid="CR16">16</xref>, <xref ref-type="bibr" rid="CR18">18</xref>]. Overlapping GGAA motifs are hidden in the interferon (IFN)-stimulated response element (ISRE)-like sequence that IRF-2 binds to and activates transcription of the <italic>ITGA2B</italic> gene [<xref ref-type="bibr" rid="CR19">19</xref>]. It has also been reported that IRF-2 drives megakaryocytic differentiation via activation of the promoter of the <italic>TPOR</italic> gene encoding a thrombopoietin receptor [<xref ref-type="bibr" rid="CR20">20</xref>]. These observations imply that transcriptional activation by the <italic>cis</italic>-acting effect of the duplicated GGAA motifs plays an important role in the differentiation of megakaryocytic cells as well as macrophage-like cells. Moreover, it has been reported that the ISRE of the mouse <italic>programmed death</italic>-<italic>1 (PDCD1)</italic> promoter contains duplication of the GGAA (TTCC) motifs and plays a role in the response to IFN-&#x003b1; in macrophages [<xref ref-type="bibr" rid="CR21">21</xref>]. The <italic>PDCD1</italic> gene encodes an immuno-regulatory receptor that belongs to the CD28 family [<xref ref-type="bibr" rid="CR22">22</xref>]. In addition, duplication of the GGAA motifs is found in the interferon-responsible promoter regions of the human <italic>interferon</italic>-<italic>stimulated gene 15 (ISG15)</italic> [<xref ref-type="bibr" rid="CR23">23</xref>] and <italic>CD40 (TNFRSF5)</italic> gene that encodes TNF receptor super family [<xref ref-type="bibr" rid="CR24">24</xref>] (Table&#x000a0;<xref rid="Tab1" ref-type="table">1</xref>). Furthermore, the GGAA motif is located in an IFN-&#x003b3; activated sequence in the <italic>transporter of antigenic peptide</italic>-<italic>1 (TAP1)</italic> promoter [<xref ref-type="bibr" rid="CR25">25</xref>]. Analysis of transcripts in purified neutrophils from active tuberclosis patients, compared with healthy controls, showed that IFNs activate JAK/STAT signal cascade to induce various gene expressions, including <italic>IRF</italic>s and various interferon-inducible genes [<xref ref-type="bibr" rid="CR26">26</xref>]. Within 500&#x000a0;bp upstream from the TSS, the duplicated GGAA (TTCC) motifs are found in 5&#x02032;-flanking regions of the <italic>OAS1</italic>, <italic>OAS2</italic>, <italic>OAS3</italic>, <italic>IFI6</italic>, <italic>IFI44</italic>, <italic>IFI44L</italic>, <italic>IFIH1</italic>, <italic>IFITM3</italic>, <italic>TAP1</italic>, <italic>GBP2</italic>, <italic>STAT1</italic>, <italic>STAT2</italic>, <italic>CD274</italic>, <italic>CXCL10</italic>, <italic>IFIT5</italic>, and <italic>IRF7</italic> genes. Therefore, the duplicated GGAA motifs and/or the recognizing factors might play a part in the regulation of those gene expressions responding to the signals evoked by IFNs. Recent study showed that IFN-&#x003b3;-producing macrophages, which co-express CD68 molecule, are identified in 70% of human melanomas [<xref ref-type="bibr" rid="CR27">27</xref>]. Although not duplicated, putative c-Ets binding motifs are found in the promoter region of the <italic>IFNG</italic> gene, suggesting that GGAA motif binding factors may co-regulate the <italic>IFNG</italic> and the <italic>CD68</italic> genes in macrophages.</p><p>As described above, the duplicated GGAA motifs are commonly found in the <italic>IL1R1</italic>, <italic>IL1R2</italic>, and <italic>IL1RAPL2</italic> gene promoter regions (Table&#x000a0;<xref rid="Tab1" ref-type="table">1</xref>). Also, the duplication of the motifs is observed in the human <italic>IL-1&#x003b2;</italic> [<xref ref-type="bibr" rid="CR28">28</xref>] (Table&#x000a0;<xref rid="Tab1" ref-type="table">1</xref>), <italic>IL-2</italic> [<xref ref-type="bibr" rid="CR29">29</xref>], and <italic>IL-2R&#x003b2;</italic> [<xref ref-type="bibr" rid="CR13">13</xref>] promoter regions. A recent study showed that Elk-1 and SRF regulate <italic>ets</italic> motif containing the <italic>ZC3H12A</italic> promoter with IL1 dependency, suggesting that the IL1 signaling system could be sensitized via the <italic>cis</italic>-acting effect of the GGAA motifs [<xref ref-type="bibr" rid="CR30">30</xref>]. In addition to the <italic>IL1R</italic> gene, <italic>IL7R</italic> gene expression could be regulated by the duplicated GGAA motif. In mouse T cells, it has been shown that GABP regulates transcription of the <italic>IL7R</italic> gene [<xref ref-type="bibr" rid="CR31">31</xref>]. It was shown that the expression of the <italic>IL7R (CD127)</italic> is strongly correlated with that of the <italic>Ets-1</italic> in human peripheral T cells [<xref ref-type="bibr" rid="CR32">32</xref>]. It could be caused by the presence of the GGAA (TTCC) duplication, 5&#x02032;-CAGAC<bold>TTCC</bold>TGTTTCT<bold>GGAA</bold>CTTGC-3&#x02032; that is located near the TSS of the human <italic>IL7R</italic> gene. Moreover, a recent study indicated that the GABP transcription factor is also required for TCR rearrangement [<xref ref-type="bibr" rid="CR33">33</xref>].</p><p>The effect of Ets proteins on the endocrine system has been investigated [<xref ref-type="bibr" rid="CR34">34</xref>]. It was recently indicated that two <italic>ets</italic> motifs located in the human <italic>insulin induced gene 2 (INSIG2)</italic> promoter play important roles in the response to insulin through binding or activation of the transcription factor, SAP1a [<xref ref-type="bibr" rid="CR35">35</xref>]. Duplication of the GGAA motifs is found in the intronic promoter region of the human Glucose-dependent insulinotoropic polypeptide-encoding gene <italic>GIP</italic> [<xref ref-type="bibr" rid="CR36">36</xref>]. The GIP can stimulate insulin release from pancreatic &#x003b2;-cells when blood glucose concentration increased [<xref ref-type="bibr" rid="CR36">36</xref>]. These lines of evidence suggest that the GGAA motifs regulate the expression of genes encoding proteins that are involved in not only cellular differentiation but also in the immuno response and endocrine systems.</p></sec><sec id="Sec4"><title>The GGAA-microsatellite-containing genes in the human genome: the main target sequences for EWS/FLI to function as an oncoprotein</title><p>Repetitive sequences are known to be located in eukaryotic chromosomes. Telomeres, which are composed of TTAGGG repeats, are located at the end of linear chromosomes [<xref ref-type="bibr" rid="CR37">37</xref>]. The centromere is a specific structural domain of the chromosome with important functions to segregate chromosomes accurately, and many protein components of the centromere have been identified [<xref ref-type="bibr" rid="CR38">38</xref>]. A centromere protein (CENP) B box, which is recognized by CENP-B, is a 17-bp motif containing GGAA and it appears within every other &#x003b1;-satellite repeat (171-bp) in human chromosomes [<xref ref-type="bibr" rid="CR39">39</xref>, <xref ref-type="bibr" rid="CR40">40</xref>]. Those repetitive sequences are generally referred as microsatellites. Ewing&#x02019;s sarcoma is a tumor in which Ets family members are involved in chromosomal translocations [<xref ref-type="bibr" rid="CR41">41</xref>]. The chromosomal translocation, t(11;22)(q24;q12) in the malignant solid tumor generates the EWS/FLI oncoprotein that functions as an aberrant transcription factor [<xref ref-type="bibr" rid="CR42">42</xref>]. The EWS/FLI oncoprotein is known to up-regulate the expression of various genes, including <italic>TGF&#x003b2; RII</italic>, <italic>cyclin D1</italic>, <italic>Id2</italic> and <italic>c-Myc</italic>, <italic>IGFBP3</italic>, <italic>PTPL1</italic>, <italic>cyclin E</italic>, <italic>MK-STYX</italic>, and <italic>caveolin1</italic>, through interaction with several <italic>ets</italic> (GGAA) motifs [<xref ref-type="bibr" rid="CR43">43</xref>]. The repetitive GGAA motifs are known as GGAA-containing microsatellites that can be targeted by the oncoprotein EWS/FLI [<xref ref-type="bibr" rid="CR42">42</xref>, <xref ref-type="bibr" rid="CR44">44</xref>]. The GGAA-containing microsatellites are located in the promoter regions of the <italic>DAX1/NR0B1</italic>, <italic>FCGRT</italic>, <italic>CAV1</italic>, <italic>CACNB2</italic>, <italic>FEZF1</italic>, <italic>KIAA1797</italic>, and <italic>GSTM4</italic> genes [<xref ref-type="bibr" rid="CR43">43</xref>, <xref ref-type="bibr" rid="CR45">45</xref>, <xref ref-type="bibr" rid="CR46">46</xref>]. Recent study suggested that EWS/FLI binds to these elements as a homodimer to activate transcription [<xref ref-type="bibr" rid="CR47">47</xref>]. The GGAA-microsatellite is preferentially recognized and activated by EWS/FLI but not by Ets1 and Elk1, suggesting that transcription of genes containing GGAA-microsatellites is not usually regulated by Ets family proteins [<xref ref-type="bibr" rid="CR47">47</xref>, <xref ref-type="bibr" rid="CR48">48</xref>].</p></sec><sec id="Sec5"><title>Identification of the duplicated GGAA motifs in the 5&#x02032;-flanking regions of various human genes</title><p>By performing transfection experiments with mutation-carrying reporter plasmids, we have indicated previously that the duplicated GGAA motifs in the 5&#x02032;-flanking regions of the <italic>PARG</italic>, <italic>IGHMBP2</italic>, <italic>ATR</italic>, <italic>XPB</italic>, <italic>RTEL</italic>, and <italic>Rb1</italic> promoters have essential roles in regulating the activities of these promoters [<xref ref-type="bibr" rid="CR10">10</xref>, <xref ref-type="bibr" rid="CR12">12</xref>, <xref ref-type="bibr" rid="CR14">14</xref>]. Comparing these duplicated GGAA motifs, we have tentatively determined the consensus 14-bp sequence as 5&#x02032;-(A/G/C)N(A/G/C)(C/G)(C/G)<bold>GGAA</bold>(A/G)(C/T)(G/C/T)(A/G/C)(A/G/C)-3&#x02032; [<xref ref-type="bibr" rid="CR14">14</xref>]. The probability of this combination occurring by chance can be roughly estimated as only once in 8,630 combinations of these bases, including the reverse orientation. The probability that the consensus 14-bp sequence would be duplicated by chance within the 50-bp distance would be extremely rare. Therefore, we explored the duplicated 14-bp sequences 2,000&#x000a0;bp upstream and 200&#x000a0;bp downstream of the TSS of 47,553 human genes extracted from the Ensembl database. The computer-based in silico analysis retrieved 469 examples with one or more duplications of the 14-bp sequence, including 234 instances of protein-encoding genes of known function or structure. Eighty percent (372/469) of the genes having consensus 14-bp sequence lacks TATA-box, and 74% (345/469) of that have GGAA(TTCC) duplications within 500&#x000a0;bp upstream (Fig.&#x000a0;<xref rid="Fig1" ref-type="fig">1</xref>). Although not all the 5&#x02032;-flanking regions of those function-known 234 genes contain the duplicated GGAA motifs within a 450-bp distance of the TSS, 174 gene promoters were found to have at least one duplicated (overlapped) GGAA motif around the TSS (Table&#x000a0;<xref rid="Tab2" ref-type="table">2</xref>, Group A). They include, for example, <italic>IFITM5</italic>, <italic>RBBP5</italic>, <italic>GRB2</italic>, and <italic>SUMO1</italic>, encoding for the interferon-induced transmembrane protein 5/Bril [<xref ref-type="bibr" rid="CR49">49</xref>], Rb-binding protein 5 [<xref ref-type="bibr" rid="CR50">50</xref>], growth factor receptor-bound protein 2 [<xref ref-type="bibr" rid="CR51">51</xref>], and small ubiquitin-modifier 1 [<xref ref-type="bibr" rid="CR52">52</xref>], respectively. The genes encoding non-degradative ubiquitin signaling factors FANCD2, which is suggested to regulate DNA replication and repair [<xref ref-type="bibr" rid="CR53">53</xref>], is included in the list (Table&#x000a0;<xref rid="Tab2" ref-type="table">2</xref>, Group B). Although our search could not retrieve the 5&#x02032;-flanking region of the <italic>BRCA1</italic> gene, the duplicated GGAA motifs are also involved in the UP site and Ets2 binding site of the human <italic>BRCA1</italic> promoter [<xref ref-type="bibr" rid="CR54">54</xref>, <xref ref-type="bibr" rid="CR55">55</xref>]. Ets2 binds to the 150-bp region upstream of the UP site that is recognized by the GABP transcription factor [<xref ref-type="bibr" rid="CR54">54</xref>]. A tumor suppressor BRCA1, which regulates DNA damage response, including cell cycle check point control and DNA repair [<xref ref-type="bibr" rid="CR56">56</xref>], has ubiquitin E3 ligase activity [<xref ref-type="bibr" rid="CR53">53</xref>, <xref ref-type="bibr" rid="CR57">57</xref>]. FANCD2, which is involved in the Fanconi anaemia pathway [<xref ref-type="bibr" rid="CR53">53</xref>], is monoubiquitylated to form Fanconi anaemia core complex with FANCI [<xref ref-type="bibr" rid="CR56">56</xref>, <xref ref-type="bibr" rid="CR58">58</xref>]. Interestingly, <italic>OTUB1</italic>, which encodes OUT domain-ubiquitin aldehyde binding 1, is included in Table&#x000a0;<xref rid="Tab2" ref-type="table">2</xref>. Recent study indicated that OTUB1 is an inhibitor of the DNA damage response that suppresses poly- but not mono-ubiquitination [<xref ref-type="bibr" rid="CR59">59</xref>]. These observations suggest that the duplicated GGAA motifs control expression of genes encoding non-degradative ubiquitylation-associated proteins. Other examples are promoter regions of genes encoding TNF-associated signal proteins such as <italic>TRAF1</italic>, <italic>TNFSF12</italic> (<italic>TWEAK</italic>), and <italic>TNFSF13 (APRIL)</italic> [<xref ref-type="bibr" rid="CR60">60</xref>&#x02013;<xref ref-type="bibr" rid="CR62">62</xref>]. The expression pattern of the <italic>TRAF1</italic> gene in HL-60 cells after TPA treatment has led to its classification as an intermediate responding gene [<xref ref-type="bibr" rid="CR4">4</xref>]. It should be noted that the GGAA motif is duplicated in the human <italic>TNF</italic> promoter region [<xref ref-type="bibr" rid="CR63">63</xref>]. Therefore, duplicated GGAA motifs could regulate expression of the genes encoding proteins that are associated with the TNF signal cascade. Moreover, several promoters of glucose metabolism associated genes (<italic>G6PD</italic>, <italic>GYS1</italic>, and <italic>SLC2A13</italic>) have been identified to contain the duplication within the 450&#x000a0;bp upstream of the TSS [<xref ref-type="bibr" rid="CR64">64</xref>&#x02013;<xref ref-type="bibr" rid="CR66">66</xref>]. Although, the algorithm used in this study could not acquire <italic>NR1H2 (LXRB)</italic> gene that was shown to be regulated by Elk1 and SRF transcription factors [<xref ref-type="bibr" rid="CR67">67</xref>], multiple GGAA (TTCC) motifs are found around the TSS of the <italic>NR1H2</italic> promoter, suggesting that the duplicated (multiple) GGAAs might also control glucose metabolism in cells.<fig id="Fig1"><label>Fig.&#x000a0;1</label><caption><p>Most of the 5&#x02032;-upstream regions having duplicated GGAA motifs are TATA-less. <bold>a</bold> The number of genes that have duplicated GGAA consensus 14-bp sequence [<xref ref-type="bibr" rid="CR14">14</xref>] in the 2,000&#x000a0;bp upstream from TSS was 469. Among them, 372 genes have no TATA-box within 500&#x000a0;bp upstream. <bold>b</bold> The number of genes that have duplicated GGAA consensus 14-bp sequencein the 2,000&#x000a0;bp upstream and GGAA(TTCC) overlapping within 500&#x000a0;bp upstream of TSS was 345. Among them, 279 genes have no TATA-box within 500&#x000a0;bp upstream. Numbers of genes from the Ensemble database are shown</p></caption><graphic xlink:href="18_2011_674_Fig1_HTML" id="MO1"/></fig><table-wrap id="Tab2"><label>Table&#x000a0;2</label><caption><p>Human promoter regions containing duplication of the GGAA motifs near the TSS</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="left" colspan="8">Group A</th><th align="left">Group B</th></tr></thead><tbody><tr><td align="left">AAGAB</td><td align="left">CPSF7</td><td align="left">FAM72D</td><td align="left">HSPA5</td><td align="left">OBP2A</td><td align="left">RBBP5</td><td align="left">SPATA2</td><td align="left">USP32</td><td align="left">ANAPC2</td></tr><tr><td align="left">ACAA1</td><td align="left">CRTC1</td><td align="left">FAM76B</td><td align="left">HSPA8</td><td align="left">OTUB1</td><td align="left">RBM33</td><td align="left">SPTAN1</td><td align="left">VPS53</td><td align="left">ARMC10</td></tr><tr><td align="left">ACOX3</td><td align="left">CXCL17</td><td align="left">FAM89A</td><td align="left">IFITM5</td><td align="left">OXT</td><td align="left">RBM34</td><td align="left">SRP19</td><td align="left">WDFY3</td><td align="left">CCNK</td></tr><tr><td align="left">AEN</td><td align="left">CYB561</td><td align="left">FAM126B</td><td align="left">IRF2BP1</td><td align="left">PAFAH1B3</td><td align="left">RDBP</td><td align="left">SSNA1</td><td align="left">WDR27</td><td align="left">CIA01</td></tr><tr><td align="left">AFAP1L2</td><td align="left">DAPK3</td><td align="left">FAM153A</td><td align="left">ITGB3BP</td><td align="left">PDGFRB</td><td align="left">R3HDM2</td><td align="left">SUMO1</td><td align="left">WDR87</td><td align="left">CNST</td></tr><tr><td align="left">AGBL5</td><td align="left">DCAF5</td><td align="left">FASN</td><td align="left">KBTBD4</td><td align="left">PEX6</td><td align="left">RPAP1</td><td align="left">SYNGAP1</td><td align="left">YRDC</td><td align="left">CRYAB</td></tr><tr><td align="left">AKAP10</td><td align="left">DDA1</td><td align="left">FBXL6</td><td align="left">KCNG4</td><td align="left">PEX14</td><td align="left">RSL1D1</td><td align="left">TFB2&#x000a0;M</td><td align="left">ZBTB17</td><td align="left">EFCAB7</td></tr><tr><td align="left">AKT3</td><td align="left">DEAF1</td><td align="left">FBXL13</td><td align="left">KCNJ2</td><td align="left">PGAP1</td><td align="left">RSL1D1</td><td align="left">TFDP2</td><td align="left">ZBTB32</td><td align="left">FANCD2</td></tr><tr><td align="left">ALDH3B1</td><td align="left">DEC1</td><td align="left">FBXW2</td><td align="left">KTI12</td><td align="left">PHOX2B</td><td align="left">RXFP4</td><td align="left">TMEM127</td><td align="left">ZBTB45</td><td align="left">IQCH</td></tr><tr><td align="left">APITD1</td><td align="left">DEFA1</td><td align="left">FCHSD2</td><td align="left">MAPKAP1</td><td align="left">PIGM</td><td align="left">SDHB</td><td align="left">TMEM161A</td><td align="left">ZC3H13</td><td align="left">LAMB2</td></tr><tr><td align="left">ARHGAP1</td><td align="left">DEFA1B</td><td align="left">FIBP</td><td align="left">MCM3AP</td><td align="left">PITX3</td><td align="left">SDK2</td><td align="left">TOMM20</td><td align="left">ZNF252</td><td align="left">MRPL32</td></tr><tr><td align="left">ARMC7</td><td align="left">DEFA3</td><td align="left">FIZ1</td><td align="left">MED8</td><td align="left">PLLP</td><td align="left">SENP1</td><td align="left">TNFSF12</td><td align="left">ZNF343</td><td align="left">NDUFB3</td></tr><tr><td align="left">BTRC</td><td align="left">DFFA</td><td align="left">GDPD2</td><td align="left">MEX3A</td><td align="left">POLD4</td><td align="left">SETD3</td><td align="left">TRAF1</td><td align="left">ZNF443</td><td align="left">NDUFS3</td></tr><tr><td align="left">CCDC79</td><td align="left">DIS3</td><td align="left">GOLGA3</td><td align="left">MGAT4B</td><td align="left">POLR2L</td><td align="left">SF3A1</td><td align="left">TRPM3</td><td align="left">ZNF555</td><td align="left">NUDT22</td></tr><tr><td align="left">CCT6A</td><td align="left">DPAGT1</td><td align="left">G6PD</td><td align="left">MUT</td><td align="left">PRELP</td><td align="left">SF3B2</td><td align="left">TRPT1</td><td align="left">ZNF558</td><td align="left">ODF3B</td></tr><tr><td align="left">CELA3B</td><td align="left">DUX4</td><td align="left">GPR155</td><td align="left">MYBBP1A</td><td align="left">P2RY14</td><td align="left">SFRS4</td><td align="left">TTC16</td><td align="left">ZNF628</td><td align="left">PDCD1</td></tr><tr><td align="left">CFL1</td><td align="left">EDC3</td><td align="left">GRB2</td><td align="left">NARS</td><td align="left">PSMA2</td><td align="left">SLC2A13</td><td align="left">TTLL8</td><td align="left">ZNF669</td><td align="left">PSPH</td></tr><tr><td align="left">CHMP1A</td><td align="left">ELAC2</td><td align="left">GYS1</td><td align="left">NBPF11</td><td align="left">PSMB1</td><td align="left">SLC3A2</td><td align="left">TYMP</td><td align="left">ZNF782</td><td align="left">SDHAF2</td></tr><tr><td align="left">CIDECP</td><td align="left">ERO1L</td><td align="left">HAS2</td><td align="left">NCAPG2</td><td align="left">PSME1</td><td align="left">SLC10A4</td><td align="left">UBE2MP1</td><td align="left">ZNF828</td><td align="left">TSPAN4</td></tr><tr><td align="left">C1QTNF6</td><td align="left">ETFA</td><td align="left">HCFC1</td><td align="left">NOC2L</td><td align="left">PURB</td><td align="left">SLC35F2</td><td align="left">UBXN1</td><td align="left">ZSCAN29</td><td align="left">VPS52</td></tr><tr><td align="left">CORT</td><td align="left">FAM49B</td><td align="left">HDHD2</td><td align="left">NT5C</td><td align="left">RAB27A</td><td align="left">SLMO2</td><td align="left">USP19</td><td align="left"/><td align="left">ZNF408</td></tr><tr><td align="left">COX17</td><td align="left">FAM70B</td><td align="left">HERC4</td><td align="left">NUP155</td><td align="left">RABL5</td><td align="left">SMUG1</td><td align="left">USP28</td><td align="left"/><td align="left"/></tr><tr><td align="left" colspan="7"/><td align="left">174 genes</td><td align="left">21 genes</td></tr></tbody></table><table-wrap-foot><p><italic>Group A</italic> The tentatively defined TPA-activation consensus 14-bp sequence, 5&#x02032;-(A/G/C)N(A/G/C)(C/G)(C/G)GGAA(A/G)(C/T)(G/C/T)(A/G/C)(A/G/C)-3&#x02032;, was searched in the Ensembl data base. Duplicated or overlapped GGAA motifs were identified near the most 5&#x02032;-upstream of those 174 genes. <italic>Group B</italic> Twenty-one genes were found to be head&#x02013;head linked with genes listed in Group A</p></table-wrap-foot></table-wrap></p><p>The tandemly repeated GGAA motifs are found in the long terminal repeat of the HIV2 gene [<xref ref-type="bibr" rid="CR68">68</xref>] and that have been identified as essential sequences in the human <italic>FcR&#x003b3;</italic> promoter [<xref ref-type="bibr" rid="CR69">69</xref>]. The locations of the <italic>ets</italic> elements in various viral gene, Fc receptor and immunoglobulin, and other promoters were reviewed previously [<xref ref-type="bibr" rid="CR70">70</xref>]. Redundancy or overlapping of the GGAA motifs in <italic>TP53</italic>, <italic>PF4 (Platelet Factor 4)</italic>, and <italic>UTRN (Utrophin)</italic> promoters has been indicated [<xref ref-type="bibr" rid="CR70">70</xref>]. These observations suggest that overlapped or tandem repeated GGAA motifs are contained in promoter regions of various genes that encode biologically important protein factors.</p></sec><sec id="Sec6"><title>Distribution of the Ets binding motifs in the whole human genome</title><p>A recent study using promoter chromatin immunoprecipitation (ChIP) microarray analysis to search for Ets family protein binding regions in the human genome indicated that promoters occupied by Ets1, ELF1, or GABP&#x003b1; were frequently bound by one or more of the other Ets proteins [<xref ref-type="bibr" rid="CR48">48</xref>]. Quantitative ChIP analysis indicated redundant binding of these transcription factors to the promoter regions of the <italic>COX17</italic> and <italic>DFFA</italic> genes that are listed in Table&#x000a0;<xref rid="Tab2" ref-type="table">2</xref> [<xref ref-type="bibr" rid="CR48">48</xref>]. Moreover, <italic>BTRC</italic> (Table&#x000a0;<xref rid="Tab2" ref-type="table">2</xref>) promoter was shown to be Ets1-RUNX1 co-occupied as <italic>TCR&#x003b1;</italic> and <italic>TCR&#x003b2;</italic> promoters [<xref ref-type="bibr" rid="CR48">48</xref>]. Thus, the genome-wide promoter ChIP analysis indicated that 5&#x02013;15% of the 17,000 human promoters are redundantly occupied by these Ets proteins. Bioinformatic studies have also indicated that Ets-like binding sites are over-represented in human promoters [<xref ref-type="bibr" rid="CR71">71</xref>&#x02013;<xref ref-type="bibr" rid="CR73">73</xref>]. Our <italic>in silico</italic> search analysis retrieved 195 (Table&#x000a0;<xref rid="Tab2" ref-type="table">2</xref>, Group A and B combined) genes that represent only 1% of total genes. This unexpectedly low value may be resulted from somewhat stringent condition for the first screening to find duplications of the <italic>PARG/IGHMBP2</italic> promoter-like GGAA motifs. Given that each Ets family protein has preferential flanking sequence of the GGAA (TTCC), our selected 14-bp might have restricted candidate genes. Recently, overlap between ChIP-seq peak data indicated several preferential combinations of the Ets family proteins that depend on cell lines used [<xref ref-type="bibr" rid="CR74">74</xref>]. The occupancy of Ets proteins in the same promoter region could be explained by alternative binding of the Ets proteins on the same binding site [<xref ref-type="bibr" rid="CR48">48</xref>]. Another explanation is that there is a separate binding site containing duplicated or overlapped GGAA (TTCC) motifs for each factor around the TSS.</p></sec><sec id="Sec7"><title>Biological properties of the Ets family proteins&#x02014;functions as proto-oncogene products</title><p>An oncogene, <italic>v-ets</italic>, was identified from the E26 avian leukemia virus in 1983 and a large family of conserved genes were isolated [<xref ref-type="bibr" rid="CR75">75</xref>, <xref ref-type="bibr" rid="CR76">76</xref>]. Several of them were targeted by homologous recombination, and it has been demonstrated that <italic>ets</italic> genes play important roles in embryogenesis and hematopoiesis [<xref ref-type="bibr" rid="CR75">75</xref>, <xref ref-type="bibr" rid="CR77">77</xref>]. The amino acid sequences of the human Ets domains were aligned and their binding sequences have been evaluated [<xref ref-type="bibr" rid="CR48">48</xref>]. The Ets family proteins not only have similarity in amino acid sequences (Ets domains) but also have similarity in their recognizing DNA sequences [<xref ref-type="bibr" rid="CR48">48</xref>]. It has been reported that the Ets transcription factor, ER81, stimulates <italic>hTERT</italic> gene expression [<xref ref-type="bibr" rid="CR78">78</xref>, <xref ref-type="bibr" rid="CR79">79</xref>]. A recent study indicated that the <italic>hTERT</italic> promoter possesses two biologically important Ets motifs (EtsA and EtsB) and that Ets2 maintains <italic>hTERT</italic> gene expression in cooperation with c-Myc in breast cancer cells [<xref ref-type="bibr" rid="CR80">80</xref>]. It is noteworthy that the TTCC motif-overlapped EtsB sequence, 5&#x02032;-<bold>TTCC</bold>T<bold>TTCC</bold>-3&#x02032;, which is the same as the one located in the <italic>eIF3A</italic> promoter (Table&#x000a0;<xref rid="Tab1" ref-type="table">1</xref>), is found close to the TSS of the <italic>hTERT</italic> gene. Analyzing sequences of the <italic>hTERT</italic> promoter from non-small cell lung cancers revealed that mutations of the TTCC motif correlate with low levels of telomerase activity and short telomeres [<xref ref-type="bibr" rid="CR81">81</xref>]. It should also be noted that palindromic Ets-binding sites are located in the promoter region of the human <italic>TP53</italic> gene and that Ets1 binds to the sequence [<xref ref-type="bibr" rid="CR70">70</xref>, <xref ref-type="bibr" rid="CR82">82</xref>]. The biological relevance of Ets1 to transcriptional activity of the <italic>TP53</italic> promoter has been shown in embryonic stem cells undergoing apoptosis induced by UV irradiation [<xref ref-type="bibr" rid="CR83">83</xref>]. A recent study indicated that the nuclear apoptosis-enhancing nuclease encoding <italic>AEN</italic> gene is a target of p53 [<xref ref-type="bibr" rid="CR84">84</xref>]. It has been reported that the death-activated protein kinase (DAPK) family modifies MDM2 and p21 proteins [<xref ref-type="bibr" rid="CR85">85</xref>]. The <italic>AEN</italic> and <italic>DAPK3</italic> promoters were identified by our search algorithm (Table&#x000a0;<xref rid="Tab2" ref-type="table">2</xref>), suggesting that genes encoding p53 and its associated proteins are commonly regulated by the duplicated GGAA motifs at the transcriptional level. Furthermore, palindromic Ets binding sites in the <italic>CRYAB (alphaB</italic>-<italic>crystallin)</italic> gene promoter are positively regulated by Ets1 in breast cancer cells [<xref ref-type="bibr" rid="CR86">86</xref>]. The epithelium-specific Ets transcription factor, ESE-1, which is abundantly expressed in human breast cancer, has been reported to have transforming activity in MCF-12A human mammary epithelial cells [<xref ref-type="bibr" rid="CR87">87</xref>]. Recently, it was shown that the Ets family member ETV1 works as a regulator of gastrointestinal stromal tumors in combination with oncogene product KIT protein [<xref ref-type="bibr" rid="CR88">88</xref>]. Whole genome sequencing analysis of human prostate cancer suggested that TMPRSS2-ERG fusion protein generated by gene rearrangement causes aberrant transcription or chromatin structure and that it is correlated with the tumorigenesis [<xref ref-type="bibr" rid="CR89">89</xref>]. As described above, the GGAA motifs are duplicated in the human <italic>PARG</italic> promoter [<xref ref-type="bibr" rid="CR10">10</xref>]. It should be noted that the duplicated GGAA motifs are located in the promoter region of the human <italic>PARP-1</italic> [<xref ref-type="bibr" rid="CR90">90</xref>] and <italic>p21</italic> [<xref ref-type="bibr" rid="CR91">91</xref>] genes, which encode poly (ADP-ribose) synthetase and Cdk inhibitor, respectively. Taken together, these observations suggest that Ets family proteins regulate cancer development or tumorigenesis.</p></sec><sec id="Sec8"><title>Apoptosis regulating functions of Ets family proteins</title><p>Apoptosis or programmed cell death is known to be regulated by various factors including caspases, DNases, or signal transduction proteins [<xref ref-type="bibr" rid="CR92">92</xref>]. The importance of Ets family proteins in the regulation of cell-death has been proposed [<xref ref-type="bibr" rid="CR75">75</xref>]. Caspase-1 has been identified as ICE (IL-1&#x003b2; converting enzyme), which plays a prominent role in inflammatory responses [<xref ref-type="bibr" rid="CR93">93</xref>, <xref ref-type="bibr" rid="CR94">94</xref>], and it is involved in the regulation of apoptosis [<xref ref-type="bibr" rid="CR95">95</xref>, <xref ref-type="bibr" rid="CR96">96</xref>]. Interestingly, it has been demonstrated that <italic>caspase-1</italic> is a direct target gene of Ets1 [<xref ref-type="bibr" rid="CR97">97</xref>]. The caspase-1 gene is also up-regulated by PU.1 in erythroleukemia cells undergoing apoptosis [<xref ref-type="bibr" rid="CR98">98</xref>, <xref ref-type="bibr" rid="CR99">99</xref>]. The activation of <italic>caspase-1</italic> gene expression could be explained by the presence of the Ets binding sequence located in the promoter region [<xref ref-type="bibr" rid="CR97">97</xref>]. Ets family proteins have been shown to regulate apoptosis of endothelial cells [<xref ref-type="bibr" rid="CR100">100</xref>, <xref ref-type="bibr" rid="CR101">101</xref>]. The repeated GGAA motifs are located in the promoter region of the human <italic>VE-cadherin</italic> gene and the Erg transcription factor has been shown to bind to that sequence in a ChIP assay [<xref ref-type="bibr" rid="CR100">100</xref>, <xref ref-type="bibr" rid="CR102">102</xref>]. Expression of antiapoptotic genes, including <italic>Bcl-XL</italic> and <italic>cIAP</italic>, is regulated by Ets1 and Ets2 during embryonic development [<xref ref-type="bibr" rid="CR101">101</xref>]. In human mesothelioma cells, Ets2 and PU.1 up-regulate <italic>Bcl-XL</italic> transcription to prevent cells from undergoing apoptosis [<xref ref-type="bibr" rid="CR103">103</xref>]. The <italic>thioredoxin-binding</italic><italic>protein 2 (TBP2)</italic> promoter, which contains multiple <italic>ets</italic> motifs, is regulated by Ets1 in the MG-63 osteosarcoma cell line [<xref ref-type="bibr" rid="CR104">104</xref>]. TBP2 is thought to cause apoptosis through activation of ASK1 and JNK [<xref ref-type="bibr" rid="CR105">105</xref>]. Moreover, the Ets1 binding site is present in the proto-oncogene <italic>Pim-3</italic> promoter [<xref ref-type="bibr" rid="CR106">106</xref>]. Up-regulated <italic>Pim-3</italic> gene expression caused by Ets1 is thought to prevent apoptosis in cancer cells. Our search indicated that <italic>PARG/IGHMBP2</italic>-like GGAA motifs are located in the promoter regions of the <italic>PDCD-1</italic> [<xref ref-type="bibr" rid="CR22">22</xref>], and <italic>DFFA</italic> genes, encoding inhibitor of caspase-activated DNase (ICAD) [<xref ref-type="bibr" rid="CR107">107</xref>]. Furthermore, the duplicated GGAA motifs are contained in the human <italic>Bcl-2</italic> [<xref ref-type="bibr" rid="CR108">108</xref>], <italic>Fas (CD95)</italic> [<xref ref-type="bibr" rid="CR109">109</xref>], and <italic>FasL</italic> [<xref ref-type="bibr" rid="CR110">110</xref>] promoter regions.</p><p>Taken together, Ets proteins could function as positive and negative apoptosis regulators controlling expression of the apoptosis signal transduction protein-encoding genes.</p></sec><sec id="Sec9"><title>The duplicated GGAA sequence functions as a fundamental transcription regulatory element for TATA-less promoters</title><p>Molecular mechanisms of the initiation of transcription by RNA-polymerase II (RNA pol II), which is involved in the large protein complex in eukaryotic cells, have been well studied [<xref ref-type="bibr" rid="CR111">111</xref>]. Sequential complex formation occurs at transcription initiation sites very close to the TATA-box where the TATA-binding protein (TBP)/TFIID complex binds first, then TFIIA, TFIIB, RNA pol II-TFIIF, TFIIE, and the DNA helicase TFIIH assemble to make a large protein complex known as the transcription machinery [<xref ref-type="bibr" rid="CR112">112</xref>]. The very first step of this RNA pol II-mediated transcription-initiating reaction begins with the recognition and binding of the TBP protein to the TATA-box. However, the TATA-box is not always found near the most 5&#x02032;-upstream region of the cDNA. It was reported that about 76% of human core promoters lack TATA-like element [<xref ref-type="bibr" rid="CR113">113</xref>]. Figure&#x000a0;<xref rid="Fig1" ref-type="fig">1</xref> shows that 81% (279/345) of the genes having duplication or more GGAA consensus 14-bp sequences [<xref ref-type="bibr" rid="CR14">14</xref>] in the 2,000-bp upstream region contain overlapped GGAA(TTCC) motifs within 500&#x000a0;bp upstream and have no TATA-box. The promoters that have no TATA-box near the TSS are usually known as TATA-less promoters, and they have a high GC content and frequently contain Sp1 binding sites, SC<bold>GGAA</bold>GY, or TGCGCANK motifs [<xref ref-type="bibr" rid="CR113">113</xref>]. If the general transcription factors need to be recruited onto the TATA-less transcription initiation site, other <italic>cis</italic>-acting sequences and binding protein factors are required for the initiation of the transcription reaction in mammalian cells.</p><p>It should be noted that the overlapping GGAA motif-containing sequence, 5&#x02032;-CCTAT<bold>GGAA</bold>ACACA<bold>GGAA</bold>GTGAC-3&#x02032;, is found in the <italic>TBP</italic> promoter region and the <italic>ets</italic> motif has been shown to play an important part in regulation of the promoter activity [<xref ref-type="bibr" rid="CR114">114</xref>]. Quantitative PCR-ChIP analysis indicated specific binding of ELK1 to the <italic>TBP</italic>, <italic>TAF1</italic>, <italic>TAF7</italic>, <italic>TAF12</italic>, <italic>GTF2A1</italic>, <italic>GTF2B</italic>, and <italic>BTAF1</italic> promoters [<xref ref-type="bibr" rid="CR115">115</xref>]. Moreover, it has been reported that the epithelium-restricted Ets transcription factor, ESX binds to TBP, and that the ETS family transcription factor, ERM, interacts with TAFII40 and TAFII60 as well as TBP [<xref ref-type="bibr" rid="CR116">116</xref>, <xref ref-type="bibr" rid="CR117">117</xref>]. Furthermore, it has been shown that PU.1 plays a role in recruiting the TBP/TFIID complex to the <italic>defensin-1</italic> promoter around the TSS [<xref ref-type="bibr" rid="CR118">118</xref>]. It should also be noted that Defensin &#x003b1;1 protein is encoded by the genes <italic>DEFA1</italic> and <italic>DEFA1B</italic> whose promoters locate tandem repeat GGAA motifs [<xref ref-type="bibr" rid="CR118">118</xref>] as listed in Table&#x000a0;<xref rid="Tab2" ref-type="table">2</xref>. These lines of evidence suggest that the ETS family proteins not only directly affect transcription of the <italic>TBP</italic> and its associated protein-encoding genes, but also guide general transcription factors, including TBP, towards the TSS of the duplicated GGAA motif-harboring promoters. Recently, the crystal structure of Elf3, which is a member of the Ets family of proteins, was revealed to bind to GGAA motifs of A- and B-sites of the <italic>type II TGF-&#x003b2; receptor</italic> (<italic>TGF-&#x003b2; RII</italic>) promoter, and it was concluded that regions flanking the Ets domain are essential for DNA binding [<xref ref-type="bibr" rid="CR119">119</xref>]. The presented model describing binding of the Elf3 with A- and B-sites in the <italic>TGF-&#x003b2; RII</italic> promoter region suggests that the duplication of the GGAA motifs might give a scaffold for general transcription factors near the TSS. In other words, tandemly repeated GGAA motifs might give rise to a fundamental position for the pre-initiation complex to bind around the TSS without TATA-box like sequences. The overlapped GGAA motifs may have advantages to control transcription precisely only by the expression levels of the Ets family members according to the behavior of cells to proliferate, differentiate, undergo apoptosis, or respond to IFN-induced signals (Fig.&#x000a0;<xref rid="Fig2" ref-type="fig">2</xref>). Therefore, it could be happening that the promoter of the same gene is active in specific cells while it is attenuated in other cells depending on the GGAA-motif binding protein expression profiles.<fig id="Fig2"><label>Fig.&#x000a0;2</label><caption><p>Hypothetical transcription controlling system in which duplicated GGAA (TTCC) motifs and Ets family proteins are involved. <italic>Closed circles</italic> represent GGAA (TTCC) motifs that are located near the TSS. The transcription activity is indicated by the size of the <italic>arrows</italic>. Multiple Ets family proteins, which are indicated by <italic>open squares</italic>, <italic>closed squares</italic>, <italic>triangles</italic>, and <italic>diamonds</italic>, could be induced by differentiation-inducing signals, apoptosis-inducing signals or specific cytokines. Their redundant occupancy around the TSS can regulate variable gene expression with subtle changes, depending on the combinations of the binding proteins. The over-transcribed mRNAs may be further regulated or fine-tuned by micro RNAs</p></caption><graphic xlink:href="18_2011_674_Fig2_HTML" id="MO2"/></fig></p></sec><sec id="Sec10"><title>Co-operation of the GGAA motifs with other transcription factor binding <italic>cis</italic>-elements near the TSS</title><p>As described above, duplicated GGAA (TTCC) motifs are found in the promoter region of the human <italic>IL-1&#x003b2;</italic> gene (Table&#x000a0;<xref rid="Tab1" ref-type="table">1</xref>). The <italic>IL-1&#x003b2;</italic> gene is synergistically regulated by PU.1 and IRFs through their binding to the PU.1/IRF composite element that is located &#x02212;2.8&#x000a0;kb from the TSS [<xref ref-type="bibr" rid="CR120">120</xref>]. The GGAA motif and other transcription factor binding site(s) can co-operatively affect promoter activity of various genes. For example, Sp1 is a transcription factor that binds to the GC boxes with the consensus sequence 5&#x02032;-(G/T)GGGCGG(G/A)(G/A)(C/T)-3&#x02032; or 5&#x02032;-(G/T)(G/A)GGCG(G/T)(G/A)(G/A)(C/T)-3&#x02032; [<xref ref-type="bibr" rid="CR121">121</xref>]. It has been reported that both the GGAA motif and the Sp1-binding element play important roles in regulating transcription of the human <italic>VE-cadherin (CDH5)</italic> [<xref ref-type="bibr" rid="CR102">102</xref>] and <italic>presenilin 1</italic><italic>(PS1)</italic> genes [<xref ref-type="bibr" rid="CR122">122</xref>]. Interactive regulatory function of the Sp1 and Ets-1 has been observed in the promoter region of the murine guanylyl cyclase/natriuretic peptide receptor-A-encoding gene, <italic>Npr1</italic> [<xref ref-type="bibr" rid="CR123">123</xref>]. Moreover, GABP and Sp1 co-operatively regulate human <italic>Heparanase1 (HPR1)</italic> promoter activity [<xref ref-type="bibr" rid="CR124">124</xref>] Oct-1, which is encoded by <italic>POU2F1</italic> gene, belongs to POU homeo-domain transcription factors [<xref ref-type="bibr" rid="CR125">125</xref>]. Members of this family recognize and bind to the octameric sequence ATGCAAAT to activate transcription of various genes [<xref ref-type="bibr" rid="CR126">126</xref>]. Oct-1 and PU.1 is involved in the control of the murine <italic>CD45 (Ptprc)</italic> promoter activity [<xref ref-type="bibr" rid="CR127">127</xref>]. Characterization of the promoter region of the <italic>Fibroleukin (FGL2)</italic> gene revealed that the <italic>cis</italic>-elements, Oct-1, Ets1 and Sp1/Sp/3, co-operatively regulate its transcription [<xref ref-type="bibr" rid="CR128">128</xref>, <xref ref-type="bibr" rid="CR129">129</xref>]. Similarly, the human <italic>BTK</italic> gene promoter, in which duplicated GGAA motif is located, is regulated by binding of Sp1/Sp3, PU.1, and Oct-1 [<xref ref-type="bibr" rid="CR130">130</xref>, <xref ref-type="bibr" rid="CR131">131</xref>]. Furthermore, c-Ets and the POU homeo-domain transcription factor, GHF-1/Pit-1 enhances Ras/Raf to activate the rat <italic>prolactin (PRL)</italic> promoter [<xref ref-type="bibr" rid="CR132">132</xref>]. Recently, it was shown that human <italic>prostacyclin receptor (PTGIR)</italic> gene promoter is regulated by Sp1, PU.1, and Oct-1 elements, and a schematic model was presented to suggest that Sp1-PU.1-Oct-1 ternary complex might recruit pre-initiation complex, including TBP, TFIID, and RNA pol II, to the TSS [<xref ref-type="bibr" rid="CR133">133</xref>]. It has been shown that Ets1 and RUNX1 bind DNA co-operatively [<xref ref-type="bibr" rid="CR48">48</xref>]. Recent genome-wide analysis of human promoters revealed that Elk1 and Ets1 bound regions are frequently occupied with SRF [<xref ref-type="bibr" rid="CR115">115</xref>], and CBP [<xref ref-type="bibr" rid="CR134">134</xref>], respectively. Moreover, it has been reported that AP1 element is co-located with ETS binding site in the promoter regions of several tumor invasion/metastasis-associated protein-encoding genes, such as <italic>MMP-1/type I collagenase</italic>, <italic>MMP-3/stromelysin</italic>, <italic>MMP-7/matrilysin</italic>, and <italic>MMP-9/type IV collagenase</italic> genes [<xref ref-type="bibr" rid="CR135">135</xref>]. Taken together, these observations suggest that transcriptional initiation may be co-regulated by the Ets family proteins in co-operation with GC-box binding factors, POU homeo-domain transcription factors, and other transcription factors including RUNX1, SRF, CBP, and AP1 binding factors at the region close to the TSS.</p></sec><sec id="Sec11"><title>Conclusion</title><p>Duplication of the GGAA motifs is found within a 500-bp distance of the TSS of various genes. Several of these genes are classified as intermediate and late responding genes during the macrophage-like differentiation of HL-60 cells induced by TPA. The duplicated GGAA motifs are located in the promoter regions of genes encoding interleukin-, interferon-, TNF-signal-associated proteins, apoptotic factors, cancer-causing proteins, tumor suppressors, or cell cycle controlling proteins including Rb and p53. Almost all these promoters have no obvious TATA-box, suggesting that the duplicated GGAA motifs play important roles in precisely recruiting the pre-initiation complex near the TSS. Redundant occupation of the duplicated GGAA motifs by Ets family proteins seems to be a complicated system, but this would enable finely tuned regulation of each promoter through altering composition of Ets family proteins or GGAA-binding proteins in the nucleus in response to cellular signals (Fig.&#x000a0;<xref rid="Fig2" ref-type="fig">2</xref>). Moreover, it is noteworthy that the duplication of the GGAA motifs contained in the 5&#x02032;-flanking region of the human <italic>TBP</italic> gene is essential for regulating promoter activity. To date, initiation of transcription is explained mainly by the binding of TBP onto the TATA-box. Here, we propose an alternative transcription initiation mechanism where the duplication of the GGAA motifs is primarily required for determining the TSS in eukaryotic cells and for regulating expression of various genes. Further investigations into the regulatory mechanisms of the duplicated GGAA motif-containing promoters will enable the development of a new treatment for leukemia and malignant tumors by introducing Ets family protein expression vectors into cells.</p></sec></body><back><ack><p>We are grateful to Dr. Atsuko Masumi for her discussion and advice. We are also grateful to Takeshi Watanabe, Takahiro Oyama, and Shizu Akasaka for their outstanding technical assistance. This work was supported in part by a Research Fellowship from the Research Center for RNA Science, RIST, Tokyo University of Science.</p><p><bold>Open Access</bold> This article is distributed under the terms of the Creative Commons Attribution Noncommercial License which permits any noncommercial use, distribution, and reproduction in any medium, provided the original author(s) and source are credited.</p></ack><ref-list id="Bib1"><title>References</title><ref id="CR1"><label>1.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Huberman</surname><given-names>E</given-names></name><name><surname>Callaham</surname><given-names>MF</given-names></name></person-group><article-title>Induction of terminal differentiation in human promyelocytic leukemia cells by tumor-promoting agents</article-title><source>Proc Natl Acad Sci USA</source><year>1979</year><volume>76</volume><fpage>1293</fpage><lpage>1297</lpage><pub-id pub-id-type="pmid">286311</pub-id></mixed-citation></ref><ref id="CR2"><label>2.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Koeffler</surname><given-names>HP</given-names></name></person-group><article-title>Human acute myeloid leukemia lines: models of leukemogenesis</article-title><source>Semin Hematol</source><year>1986</year><volume>23</volume><fpage>223</fpage><lpage>236</lpage><pub-id pub-id-type="pmid">3092357</pub-id></mixed-citation></ref><ref id="CR3"><label>3.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Collins</surname><given-names>SJ</given-names></name></person-group><article-title>The HL-60 promyelocytic leukemia cell line: proliferation, differentiation, and cellular oncogene expression</article-title><source>Blood</source><year>1987</year><volume>70</volume><fpage>1233</fpage><lpage>1244</lpage><pub-id pub-id-type="pmid">3311197</pub-id></mixed-citation></ref><ref id="CR4"><label>4.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zheng</surname><given-names>X</given-names></name><name><surname>Ravatn</surname><given-names>R</given-names></name><name><surname>Lin</surname><given-names>Y</given-names></name><name><surname>Shih</surname><given-names>W-C</given-names></name><name><surname>Rabson</surname><given-names>A</given-names></name><name><surname>Strair</surname><given-names>R</given-names></name><name><surname>Huberman</surname><given-names>E</given-names></name><name><surname>Conney</surname><given-names>A</given-names></name><name><surname>Chin</surname><given-names>KV</given-names></name></person-group><article-title>Gene expression of TPA induced differentiation in HL-60 cells by DNA microarray analysis</article-title><source>Nucleic Acids Res</source><year>2002</year><volume>30</volume><fpage>4489</fpage><lpage>4499</lpage><pub-id pub-id-type="pmid">12384596</pub-id></mixed-citation></ref><ref id="CR5"><label>5.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Han</surname><given-names>ZT</given-names></name><name><surname>Zhu</surname><given-names>XX</given-names></name><name><surname>Yang</surname><given-names>RY</given-names></name><name><surname>Sun</surname><given-names>JZ</given-names></name><name><surname>Tian</surname><given-names>GF</given-names></name><name><surname>Liu</surname><given-names>XJ</given-names></name><name><surname>Cao</surname><given-names>GS</given-names></name><name><surname>Newmark</surname><given-names>HL</given-names></name><name><surname>Conney</surname><given-names>AH</given-names></name><name><surname>Chang</surname><given-names>RL</given-names></name></person-group><article-title>Effect of intravenous infusions of 12-<italic>O</italic>-tetradecanoylphorbol-13-acetate (TPA) in patients with myelocytic leukemia: preliminary studies on therapeutic efficacy and toxicity</article-title><source>Proc Natl Acad Sci USA</source><year>1998</year><volume>95</volume><fpage>5357</fpage><lpage>5361</lpage><pub-id pub-id-type="pmid">9560280</pub-id></mixed-citation></ref><ref id="CR6"><label>6.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Han</surname><given-names>ZT</given-names></name><name><surname>Tong</surname><given-names>YK</given-names></name><name><surname>He</surname><given-names>LM</given-names></name><name><surname>Zhang</surname><given-names>Y</given-names></name><name><surname>Sun</surname><given-names>JZ</given-names></name><name><surname>Wang</surname><given-names>TY</given-names></name><name><surname>Zhang</surname><given-names>H</given-names></name><name><surname>Cui</surname><given-names>YL</given-names></name><name><surname>Newmark</surname><given-names>HL</given-names></name><name><surname>Conney</surname><given-names>AH</given-names></name><name><surname>Chang</surname><given-names>RL</given-names></name></person-group><article-title>12-<italic>O</italic>-tetradecanoylphorbol-13-acetate (TPA)-induced increase in depressed white blood cell counts in patients treated with cytotoxic cancer chemotherapeutic drugs</article-title><source>Proc Natl Acad Sci USA</source><year>1998</year><volume>95</volume><fpage>5362</fpage><lpage>5365</lpage><pub-id pub-id-type="pmid">9560281</pub-id></mixed-citation></ref><ref id="CR7"><label>7.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Strair</surname><given-names>RK</given-names></name><name><surname>Schaar</surname><given-names>D</given-names></name><name><surname>Goodell</surname><given-names>L</given-names></name><name><surname>Aisner</surname><given-names>J</given-names></name><name><surname>Chin</surname><given-names>KV</given-names></name><name><surname>Eid</surname><given-names>J</given-names></name><name><surname>Senzon</surname><given-names>R</given-names></name><name><surname>Cui</surname><given-names>XX</given-names></name><name><surname>Han</surname><given-names>ZT</given-names></name><name><surname>Knox</surname><given-names>B</given-names></name><name><surname>Rabson</surname><given-names>AB</given-names></name><name><surname>Chang</surname><given-names>R</given-names></name><name><surname>Conney</surname><given-names>A</given-names></name></person-group><article-title>Administration of a phorbol ester to patients with hematological malignancies: preliminary results from a phase I clinical trial of 12-<italic>O</italic>-tetradecanoylphorbol-13-acetate</article-title><source>Clin Cancer Res</source><year>2002</year><volume>8</volume><fpage>2512</fpage><lpage>2518</lpage><pub-id pub-id-type="pmid">12171877</pub-id></mixed-citation></ref><ref id="CR8"><label>8.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Takahashi</surname><given-names>K</given-names></name><name><surname>Yamanaka</surname><given-names>S</given-names></name></person-group><article-title>Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors</article-title><source>Cell</source><year>2006</year><volume>126</volume><fpage>663</fpage><lpage>676</lpage><pub-id pub-id-type="pmid">16904174</pub-id></mixed-citation></ref><ref id="CR9"><label>9.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Takahashi</surname><given-names>K</given-names></name><name><surname>Tanabe</surname><given-names>K</given-names></name><name><surname>Ohnuki</surname><given-names>M</given-names></name><name><surname>Narita</surname><given-names>M</given-names></name><name><surname>Ichisaka</surname><given-names>T</given-names></name><name><surname>Tomoda</surname><given-names>K</given-names></name><name><surname>Yamanaka</surname><given-names>S</given-names></name></person-group><article-title>Induction of pluripotent stem cells from adult human fibroblasts by defined factors</article-title><source>Cell</source><year>2007</year><volume>131</volume><fpage>861</fpage><lpage>872</lpage><pub-id pub-id-type="pmid">18035408</pub-id></mixed-citation></ref><ref id="CR10"><label>10.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Uchiumi</surname><given-names>F</given-names></name><name><surname>Sakakibara</surname><given-names>G</given-names></name><name><surname>Sato</surname><given-names>J</given-names></name><name><surname>Tanuma</surname><given-names>S</given-names></name></person-group><article-title>Characterization of the promoter region of the human <italic>PARG</italic> gene and its response to PU.1 during differentiation of HL-60 cells</article-title><source>Genes Cells</source><year>2008</year><volume>13</volume><fpage>1229</fpage><lpage>1247</lpage><pub-id pub-id-type="pmid">19076642</pub-id></mixed-citation></ref><ref id="CR11"><label>11.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Uchiumi</surname><given-names>F</given-names></name><name><surname>Komuro</surname><given-names>M</given-names></name><name><surname>Mizuta</surname><given-names>R</given-names></name><name><surname>Tanuma</surname><given-names>S</given-names></name></person-group><article-title>Characterization of Smubp-2 as a mouse mammary tumor virus promoter-binding protein</article-title><source>Biochem Biophys Res Commun</source><year>2004</year><volume>321</volume><fpage>355</fpage><lpage>363</lpage><pub-id pub-id-type="pmid">15358184</pub-id></mixed-citation></ref><ref id="CR12"><label>12.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Uchiumi</surname><given-names>F</given-names></name><name><surname>Enokida</surname><given-names>K</given-names></name><name><surname>Shiraishi</surname><given-names>T</given-names></name><name><surname>Masumi</surname><given-names>A</given-names></name><name><surname>Tanuma</surname><given-names>S</given-names></name></person-group><article-title>Characterization of the promoter region of the human <italic>IGHMBP2 (S&#x003bc;bp</italic>-<italic>2)</italic> gene and its response to TPA in HL-60 cells</article-title><source>Gene</source><year>2010</year><volume>463</volume><fpage>8</fpage><lpage>17</lpage><pub-id pub-id-type="pmid">20441787</pub-id></mixed-citation></ref><ref id="CR13"><label>13.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lin</surname><given-names>J-X</given-names></name><name><surname>Bhat</surname><given-names>NK</given-names></name><name><surname>John</surname><given-names>S</given-names></name><name><surname>Queale</surname><given-names>WS</given-names></name><name><surname>Leonard</surname><given-names>WJ</given-names></name></person-group><article-title>Characterization of the human interleukin-2 receptor &#x003b2;-chain gene promoter: regulation of promoter activity by <italic>ets</italic> gene products</article-title><source>Mol Cell Biol</source><year>1993</year><volume>13</volume><fpage>6201</fpage><lpage>6210</lpage><pub-id pub-id-type="pmid">8413220</pub-id></mixed-citation></ref><ref id="CR14"><label>14.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Uchiumi</surname><given-names>F</given-names></name><name><surname>Watanabe</surname><given-names>T</given-names></name><name><surname>Tanuma</surname><given-names>S</given-names></name></person-group><article-title>Characterization of various promoter regions of human DNA helicase-encoding genes and identification of duplicated <italic>ets</italic> (GGAA) motifs as an essential transcription regulatory element</article-title><source>Exp Cell Res</source><year>2010</year><volume>316</volume><fpage>1523</fpage><lpage>1534</lpage><pub-id pub-id-type="pmid">20302858</pub-id></mixed-citation></ref><ref id="CR15"><label>15.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>O&#x02019;Reilly</surname><given-names>D</given-names></name><name><surname>Quinn</surname><given-names>CM</given-names></name><name><surname>El-Shanawany</surname><given-names>T</given-names></name><name><surname>Gordon</surname><given-names>S</given-names></name><name><surname>Greaves</surname><given-names>DR</given-names></name></person-group><article-title>Multiple Ets factors and interferon regulatory factor-4 modulate <italic>CD68</italic> expression in a cell type-specific manner</article-title><source>J Biol Chem</source><year>2003</year><volume>278</volume><fpage>21909</fpage><lpage>21919</lpage><pub-id pub-id-type="pmid">12676954</pub-id></mixed-citation></ref><ref id="CR16"><label>16.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sevinsky</surname><given-names>JR</given-names></name><name><surname>Whalen</surname><given-names>AM</given-names></name><name><surname>Ahn</surname><given-names>NG</given-names></name></person-group><article-title>Extracellular signal-regulated kinase induces the megakaryocyte GPIIb/CD41 gene through MafB/Kreisler</article-title><source>Mol Cell Biol</source><year>2004</year><volume>24</volume><fpage>4534</fpage><lpage>4545</lpage><pub-id pub-id-type="pmid">15121870</pub-id></mixed-citation></ref><ref id="CR17"><label>17.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Phillips</surname><given-names>DR</given-names></name><name><surname>Charo</surname><given-names>IF</given-names></name><name><surname>Parise</surname><given-names>LV</given-names></name><name><surname>Fitzgerald</surname><given-names>LA</given-names></name></person-group><article-title>The platelet membrane glycoprotein IIb-IIIa complex</article-title><source>Blood</source><year>1988</year><volume>71</volume><fpage>831</fpage><lpage>843</lpage><pub-id pub-id-type="pmid">2833328</pub-id></mixed-citation></ref><ref id="CR18"><label>18.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dorsey</surname><given-names>JF</given-names></name><name><surname>Cunnick</surname><given-names>JM</given-names></name><name><surname>Mane</surname><given-names>SM</given-names></name><name><surname>Wu</surname><given-names>J</given-names></name></person-group><article-title>Regulation of the Erk2-Elk1 signaling pathway and megakaryocytic differentiation of Bcr-Abl(+) K562 leukemic cells by Gab2</article-title><source>Blood</source><year>2002</year><volume>99</volume><fpage>1388</fpage><lpage>1397</lpage><pub-id pub-id-type="pmid">11830491</pub-id></mixed-citation></ref><ref id="CR19"><label>19.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Masumi</surname><given-names>A</given-names></name><name><surname>Hamaguchi</surname><given-names>I</given-names></name><name><surname>Kuramitsu</surname><given-names>M</given-names></name><name><surname>Mizukami</surname><given-names>T</given-names></name><name><surname>Takizawa</surname><given-names>K</given-names></name><name><surname>Momose</surname><given-names>H</given-names></name><name><surname>Naito</surname><given-names>S</given-names></name><name><surname>Yamaguchi</surname><given-names>K</given-names></name></person-group><article-title>Interferon regulatory factor-2 induces megakaryopoiesis in mouse bone marrow hematopoietic cells</article-title><source>FEBS Lett</source><year>2009</year><volume>583</volume><fpage>3493</fpage><lpage>3500</lpage><pub-id pub-id-type="pmid">19818776</pub-id></mixed-citation></ref><ref id="CR20"><label>20.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Stellacci</surname><given-names>E</given-names></name><name><surname>Testa</surname><given-names>U</given-names></name><name><surname>Petrucci</surname><given-names>E</given-names></name><name><surname>Bendetti</surname><given-names>E</given-names></name><name><surname>Orsatti</surname><given-names>R</given-names></name><name><surname>Feccia</surname><given-names>T</given-names></name><name><surname>Stafsnes</surname><given-names>M</given-names></name><name><surname>Marziali</surname><given-names>G</given-names></name><name><surname>Battistini</surname><given-names>A</given-names></name></person-group><article-title>Interferon regulatory factor-2 drives megakaryocytic differentiation</article-title><source>Biochem J</source><year>2004</year><volume>377</volume><fpage>367</fpage><lpage>378</lpage><pub-id pub-id-type="pmid">14505489</pub-id></mixed-citation></ref><ref id="CR21"><label>21.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cho</surname><given-names>HY</given-names></name><name><surname>Lee</surname><given-names>SW</given-names></name><name><surname>Seo</surname><given-names>SK</given-names></name><name><surname>Choi</surname><given-names>IW</given-names></name><name><surname>Choi</surname><given-names>I</given-names></name><name><surname>Lee</surname><given-names>SW</given-names></name></person-group><article-title>Interferon-sensitive response element (ISRE) is mainly responsible for IFN-&#x003b1;-induced upregulation of programmed death-1 (PD-1) in macrophages</article-title><source>Biochim Biophys Acta</source><year>2008</year><volume>1779</volume><fpage>811</fpage><lpage>819</lpage><pub-id pub-id-type="pmid">18771758</pub-id></mixed-citation></ref><ref id="CR22"><label>22.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chen</surname><given-names>L</given-names></name></person-group><article-title>Co-inhibitory molecules of the B7-CD28 family in the control of T-cell immunity</article-title><source>Nat Rev Immunol</source><year>2004</year><volume>4</volume><fpage>336</fpage><lpage>347</lpage><pub-id pub-id-type="pmid">15122199</pub-id></mixed-citation></ref><ref id="CR23"><label>23.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Perry</surname><given-names>DJ</given-names></name><name><surname>Austin</surname><given-names>KJ</given-names></name><name><surname>Hansen</surname><given-names>TR</given-names></name></person-group><article-title>Cloning of interferon-stimulated gene 17: the promoter and nuclear proteins that regulate transcription</article-title><source>Mol Endocrinol</source><year>1999</year><volume>13</volume><fpage>1197</fpage><lpage>1206</lpage><pub-id pub-id-type="pmid">10406469</pub-id></mixed-citation></ref><ref id="CR24"><label>24.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nguyen</surname><given-names>VT</given-names></name><name><surname>Benveniste</surname><given-names>EN</given-names></name></person-group><article-title>Involvement of STAT-1 and Ets family members in interferon-&#x003b3; induction of CD40 transcription in microglia/macrophages</article-title><source>J Biol Chem</source><year>2000</year><volume>275</volume><fpage>23674</fpage><lpage>23684</lpage><pub-id pub-id-type="pmid">10823830</pub-id></mixed-citation></ref><ref id="CR25"><label>25.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rouyez</surname><given-names>MC</given-names></name><name><surname>Lestingi</surname><given-names>M</given-names></name><name><surname>Charon</surname><given-names>M</given-names></name><name><surname>Fichelson</surname><given-names>S</given-names></name><name><surname>Buzyn</surname><given-names>A</given-names></name><name><surname>Dusanter-Fourt</surname><given-names>I</given-names></name></person-group><article-title>IFN regulatory factor-2 cooperates with STAT1 to regulate transporter associated with antigen processing-1 promoter activity</article-title><source>J Immunol</source><year>2005</year><volume>174</volume><fpage>3948</fpage><lpage>3958</lpage><pub-id pub-id-type="pmid">15778351</pub-id></mixed-citation></ref><ref id="CR26"><label>26.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Berry</surname><given-names>MPR</given-names></name><name><surname>Graham</surname><given-names>CM</given-names></name><name><surname>McNab</surname><given-names>FW</given-names></name><name><surname>Xu</surname><given-names>Z</given-names></name><name><surname>Bloch</surname><given-names>SAA</given-names></name><name><surname>Oni</surname><given-names>T</given-names></name><name><surname>Wilkinson</surname><given-names>KA</given-names></name><name><surname>Banchereau</surname><given-names>R</given-names></name><name><surname>Skinner</surname><given-names>J</given-names></name><name><surname>Wilkinson</surname><given-names>RJ</given-names></name><name><surname>Quinn</surname><given-names>C</given-names></name><name><surname>Blankenship</surname><given-names>D</given-names></name><name><surname>Dhawan</surname><given-names>R</given-names></name><name><surname>Cush</surname><given-names>JJ</given-names></name><name><surname>Mejias</surname><given-names>A</given-names></name><name><surname>Ramilo</surname><given-names>O</given-names></name><name><surname>Kon</surname><given-names>OM</given-names></name><name><surname>Pascual</surname><given-names>V</given-names></name><name><surname>Banchereau</surname><given-names>J</given-names></name><name><surname>Chaussabel</surname><given-names>D</given-names></name><name><surname>O&#x02019;Garra</surname><given-names>A</given-names></name></person-group><article-title>An interferon-inducible neutrophil-driven blood transcriptional signature in human tuberculosis</article-title><source>Nature</source><year>2010</year><volume>466</volume><fpage>973</fpage><lpage>977</lpage><pub-id pub-id-type="pmid">20725040</pub-id></mixed-citation></ref><ref id="CR27"><label>27.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zaidi</surname><given-names>MR</given-names></name><name><surname>Davis</surname><given-names>S</given-names></name><name><surname>Noonan</surname><given-names>FP</given-names></name><name><surname>Graff-Cherry</surname><given-names>C</given-names></name><name><surname>Hawley</surname><given-names>TS</given-names></name><name><surname>Walker</surname><given-names>RL</given-names></name><name><surname>Feigenbaum</surname><given-names>L</given-names></name><name><surname>Fuchs</surname><given-names>E</given-names></name><name><surname>Lyakh</surname><given-names>L</given-names></name><name><surname>Young</surname><given-names>HA</given-names></name><name><surname>Hornyak</surname><given-names>TJ</given-names></name><name><surname>Arnheiter</surname><given-names>H</given-names></name><name><surname>Trinchieri</surname><given-names>G</given-names></name><name><surname>Meltzer</surname><given-names>PS</given-names></name><name><surname>Fabo</surname><given-names>EC</given-names></name><name><surname>Merlino</surname><given-names>G</given-names></name></person-group><article-title>Interferon-&#x003b3; links ultraviolet radiation to melanomagenesis in mice</article-title><source>Nature</source><year>2011</year><volume>469</volume><fpage>548</fpage><lpage>553</lpage><pub-id pub-id-type="pmid">21248750</pub-id></mixed-citation></ref><ref id="CR28"><label>28.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yang</surname><given-names>Z</given-names></name><name><surname>Wara-Aswapati</surname><given-names>N</given-names></name><name><surname>Chen</surname><given-names>C</given-names></name><name><surname>Tsukada</surname><given-names>J</given-names></name><name><surname>Auron</surname><given-names>PE</given-names></name></person-group><article-title>NF-IL6 (C/EBP&#x003b2;) vigorously activates <italic>il1b</italic> gene expression via a Spi-1 (PU.1) protein-protein tether</article-title><source>J Biol Chem</source><year>2000</year><volume>275</volume><fpage>21272</fpage><lpage>21277</lpage><pub-id pub-id-type="pmid">10801783</pub-id></mixed-citation></ref><ref id="CR29"><label>29.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Avots</surname><given-names>A</given-names></name><name><surname>Hoffmeyer</surname><given-names>A</given-names></name><name><surname>Flory</surname><given-names>E</given-names></name><name><surname>Cimanis</surname><given-names>A</given-names></name><name><surname>Rapp</surname><given-names>UR</given-names></name><name><surname>Serfling</surname><given-names>E</given-names></name></person-group><article-title>GABP factors bind to a distal interleukin 2 (IL-2) enhancer and contribute to c-Raf-mediated increase in IL-2 induction</article-title><source>Mol Cell Biol</source><year>1997</year><volume>17</volume><fpage>4381</fpage><lpage>4389</lpage><pub-id pub-id-type="pmid">9234696</pub-id></mixed-citation></ref><ref id="CR30"><label>30.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kasza</surname><given-names>A</given-names></name><name><surname>Wyrzykowska</surname><given-names>P</given-names></name><name><surname>Horwacik</surname><given-names>I</given-names></name><name><surname>Tymoszuk</surname><given-names>P</given-names></name><name><surname>Mizgalska</surname><given-names>D</given-names></name><name><surname>Palmer</surname><given-names>K</given-names></name><name><surname>Rokita</surname><given-names>H</given-names></name><name><surname>Sharrocks</surname><given-names>AD</given-names></name><name><surname>Jura</surname><given-names>J</given-names></name></person-group><article-title>Transcription factors Elk-1 and SRF are engaged in IL1-dependent regulation of <italic>ZC3H12A</italic> expression</article-title><source>BMC Mol Biol</source><year>2010</year><volume>11</volume><fpage>14</fpage><pub-id pub-id-type="pmid">20137095</pub-id></mixed-citation></ref><ref id="CR31"><label>31.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Xue</surname><given-names>HH</given-names></name><name><surname>Bollenbacher</surname><given-names>J</given-names></name><name><surname>Rovella</surname><given-names>V</given-names></name><name><surname>Tripuraneni</surname><given-names>R</given-names></name><name><surname>Du</surname><given-names>YB</given-names></name><name><surname>Liu</surname><given-names>CY</given-names></name><name><surname>Williams</surname><given-names>A</given-names></name><name><surname>McCoy</surname><given-names>JP</given-names></name><name><surname>Leonard</surname><given-names>WJ</given-names></name></person-group><article-title>GA binding protein regulates interleukin 7 receptor alpha-chain gene expression in T cells</article-title><source>Nat Immunol</source><year>2004</year><volume>5</volume><fpage>1036</fpage><lpage>1044</lpage><pub-id pub-id-type="pmid">15361867</pub-id></mixed-citation></ref><ref id="CR32"><label>32.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Grenningloh</surname><given-names>R</given-names></name><name><surname>Tai</surname><given-names>TS</given-names></name><name><surname>Frahm</surname><given-names>N</given-names></name><name><surname>Hongo</surname><given-names>TC</given-names></name><name><surname>Chicoine</surname><given-names>AT</given-names></name><name><surname>Brander</surname><given-names>C</given-names></name><name><surname>Kaufmann</surname><given-names>DE</given-names></name><name><surname>Ho</surname><given-names>IC</given-names></name></person-group><article-title>Ets-1 maintains IL-7 receptor expression in peripheral T cells</article-title><source>J Immunol</source><year>2011</year><volume>186</volume><fpage>969</fpage><lpage>976</lpage><pub-id pub-id-type="pmid">21148801</pub-id></mixed-citation></ref><ref id="CR33"><label>33.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yu</surname><given-names>S</given-names></name><name><surname>Zhao</surname><given-names>DM</given-names></name><name><surname>Jothi</surname><given-names>R</given-names></name><name><surname>Xue</surname><given-names>HH</given-names></name></person-group><article-title>Critical requirement of GABPalpha for normal T cell development</article-title><source>J Biol Chem</source><year>2010</year><volume>285</volume><fpage>10179</fpage><lpage>10188</lpage><pub-id pub-id-type="pmid">20139079</pub-id></mixed-citation></ref><ref id="CR34"><label>34.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Guitierrez-Hartmann</surname><given-names>A</given-names></name><name><surname>Duval</surname><given-names>DL</given-names></name><name><surname>Bradford</surname><given-names>AP</given-names></name></person-group><article-title>ETS transcription factors in endocrine systems</article-title><source>Trends Endocrinol Metab</source><year>2007</year><volume>18</volume><fpage>150</fpage><lpage>158</lpage><pub-id pub-id-type="pmid">17387021</pub-id></mixed-citation></ref><ref id="CR35"><label>35.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fern&#x000e1;ndez-Alvarez</surname><given-names>A</given-names></name><name><surname>Soledad Alvarez</surname><given-names>M</given-names></name><name><surname>Cucarella</surname><given-names>C</given-names></name><name><surname>Casado</surname><given-names>M</given-names></name></person-group><article-title>Characterization of the human insulin-induced gene 2 (INSIG2) promoter: the role of Ets-binding motifs</article-title><source>J Biol Chem</source><year>2010</year><volume>285</volume><fpage>11765</fpage><lpage>11774</lpage><pub-id pub-id-type="pmid">20145255</pub-id></mixed-citation></ref><ref id="CR36"><label>36.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hoo</surname><given-names>RLC</given-names></name><name><surname>Chu</surname><given-names>JYS</given-names></name><name><surname>Yuan</surname><given-names>Y</given-names></name><name><surname>Yeung</surname><given-names>CM</given-names></name><name><surname>Chan</surname><given-names>KYY</given-names></name><name><surname>Chow</surname><given-names>BKC</given-names></name></person-group><article-title>Functional identification of an intronic promoter of the human glucose-dependent insulinotropic peptide gene</article-title><source>Gene</source><year>2010</year><volume>463</volume><fpage>29</fpage><lpage>40</lpage><pub-id pub-id-type="pmid">20452407</pub-id></mixed-citation></ref><ref id="CR37"><label>37.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Blackburn</surname><given-names>EH</given-names></name></person-group><article-title>The end of the (DNA) line</article-title><source>Nat Struct Biol</source><year>2000</year><volume>7</volume><fpage>847</fpage><lpage>850</lpage><pub-id pub-id-type="pmid">11017190</pub-id></mixed-citation></ref><ref id="CR38"><label>38.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Warburton</surname><given-names>PE</given-names></name></person-group><article-title>Epigenetic analysis of kinetochore assembly on variant human centromeres</article-title><source>Trends Genet</source><year>2001</year><volume>17</volume><fpage>243</fpage><lpage>247</lpage><pub-id pub-id-type="pmid">11335021</pub-id></mixed-citation></ref><ref id="CR39"><label>39.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sugimoto</surname><given-names>K</given-names></name><name><surname>Shibata</surname><given-names>A</given-names></name><name><surname>Himeno</surname><given-names>M</given-names></name></person-group><article-title>Nucleotide specificity at the boundary and size requirement of the target sites recognized by human centromere protein (CENP-B) in vitro</article-title><source>Chromosome Res</source><year>1998</year><volume>6</volume><fpage>133</fpage><lpage>140</lpage><pub-id pub-id-type="pmid">9543016</pub-id></mixed-citation></ref><ref id="CR40"><label>40.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ohzeki</surname><given-names>J</given-names></name><name><surname>Nakano</surname><given-names>M</given-names></name><name><surname>Okada</surname><given-names>T</given-names></name><name><surname>Masumoto</surname><given-names>H</given-names></name></person-group><article-title>CENP-B box is required for de novo centromere chromatin assembly on human alphoid DNA</article-title><source>J Cell Biol</source><year>2002</year><volume>159</volume><fpage>765</fpage><lpage>775</lpage><pub-id pub-id-type="pmid">12460987</pub-id></mixed-citation></ref><ref id="CR41"><label>41.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Delattre</surname><given-names>O</given-names></name><name><surname>Zucman</surname><given-names>J</given-names></name><name><surname>Plougastel</surname><given-names>B</given-names></name><name><surname>Desmaze</surname><given-names>C</given-names></name><name><surname>Melot</surname><given-names>T</given-names></name><name><surname>Peter</surname><given-names>M</given-names></name><name><surname>Kovar</surname><given-names>H</given-names></name><name><surname>Joubert</surname><given-names>I</given-names></name><name><surname>Jong</surname><given-names>P</given-names></name><name><surname>Rouleau</surname><given-names>G</given-names></name><name><surname>Aurias</surname><given-names>A</given-names></name><name><surname>Thomas</surname><given-names>G</given-names></name></person-group><article-title>Gene function with an ETS DNA-binding domain caused by chromosome translocation in human tumors</article-title><source>Nature</source><year>1992</year><volume>359</volume><fpage>162</fpage><lpage>165</lpage><pub-id pub-id-type="pmid">1522903</pub-id></mixed-citation></ref><ref id="CR42"><label>42.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gangwal</surname><given-names>K</given-names></name><name><surname>Sankar</surname><given-names>S</given-names></name><name><surname>Hollenhorst</surname><given-names>PC</given-names></name><name><surname>Kinsey</surname><given-names>M</given-names></name><name><surname>Haroldsen</surname><given-names>SC</given-names></name><name><surname>Shah</surname><given-names>AA</given-names></name><name><surname>Boucher</surname><given-names>KM</given-names></name><name><surname>Watkins</surname><given-names>WS</given-names></name><name><surname>Jorde</surname><given-names>LB</given-names></name><name><surname>Graves</surname><given-names>BJ</given-names></name><name><surname>Lessnick</surname><given-names>L</given-names></name></person-group><article-title>Microsatellites as EWS/FLI response elements in Ewing&#x02019;s sarcoma</article-title><source>Proc Natl Acad Sci USA</source><year>2008</year><volume>105</volume><fpage>10149</fpage><lpage>10154</lpage><pub-id pub-id-type="pmid">18626011</pub-id></mixed-citation></ref><ref id="CR43"><label>43.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Guillon</surname><given-names>N</given-names></name><name><surname>Tirode</surname><given-names>F</given-names></name><name><surname>Boeva</surname><given-names>V</given-names></name><name><surname>Zynovyev</surname><given-names>A</given-names></name><name><surname>Barillot</surname><given-names>E</given-names></name><name><surname>Delattre</surname><given-names>O</given-names></name></person-group><article-title>The oncogenic EWS-FLI1 protein binds in vivo GGAA microsatellite sequences with potential transcriptional activation function</article-title><source>PLoS One</source><year>2009</year><volume>4</volume><fpage>e4932</fpage><pub-id pub-id-type="pmid">19305498</pub-id></mixed-citation></ref><ref id="CR44"><label>44.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kovar</surname><given-names>H</given-names></name></person-group><article-title>Downstream EWS/FLI1&#x02014;upstream Ewing&#x02019;s sarcoma</article-title><source>Genome Med</source><year>2010</year><volume>2</volume><fpage>8</fpage><pub-id pub-id-type="pmid">20156317</pub-id></mixed-citation></ref><ref id="CR45"><label>45.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Luo</surname><given-names>W</given-names></name><name><surname>Gangwal</surname><given-names>K</given-names></name><name><surname>Sankar</surname><given-names>S</given-names></name><name><surname>Boucher</surname><given-names>KM</given-names></name><name><surname>Thomas</surname><given-names>D</given-names></name><name><surname>Lessnick</surname><given-names>SL</given-names></name></person-group><article-title><italic>GSTM4</italic> is a microsatellite-containing EWS/FLI target involved in Ewing&#x02019;s sarcoma oncogenesis and therapeutic resistance</article-title><source>Oncogene</source><year>2009</year><volume>28</volume><fpage>4126</fpage><lpage>4132</lpage><pub-id pub-id-type="pmid">19718047</pub-id></mixed-citation></ref><ref id="CR46"><label>46.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Garcia-Aragoncillo</surname><given-names>E</given-names></name><name><surname>Carrillo</surname><given-names>J</given-names></name><name><surname>Lalli</surname><given-names>E</given-names></name><name><surname>Agra</surname><given-names>N</given-names></name><name><surname>Gomez-Lopez</surname><given-names>G</given-names></name><name><surname>Pestana</surname><given-names>A</given-names></name><name><surname>Alonso</surname><given-names>J</given-names></name></person-group><article-title>DAX1, a direct target of EWS/FLI1 oncoprotein, is a principal regulator of cell-cycle progression in Ewing&#x02019;s tumor cells</article-title><source>Oncogene</source><year>2008</year><volume>27</volume><fpage>6034</fpage><lpage>6043</lpage><pub-id pub-id-type="pmid">18591936</pub-id></mixed-citation></ref><ref id="CR47"><label>47.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gangwal</surname><given-names>K</given-names></name><name><surname>Close</surname><given-names>D</given-names></name><name><surname>Enriquez</surname><given-names>CA</given-names></name><name><surname>Hill</surname><given-names>CP</given-names></name><name><surname>Lessnick</surname><given-names>SL</given-names></name></person-group><article-title>Emergent properties of EWS/FLI regulation via GGAA microsatellites in Ewing&#x02019;s sarcoma</article-title><source>Genes Cancer</source><year>2010</year><volume>1</volume><fpage>177</fpage><lpage>187</lpage><pub-id pub-id-type="pmid">20827386</pub-id></mixed-citation></ref><ref id="CR48"><label>48.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hollenhorst</surname><given-names>PC</given-names></name><name><surname>Shah</surname><given-names>AA</given-names></name><name><surname>Hopkins</surname><given-names>C</given-names></name><name><surname>Graves</surname><given-names>BJ</given-names></name></person-group><article-title>Genome-wide analyses reveal properties of redundant and specific promoter occupancy within the <italic>ETS</italic> gene family</article-title><source>Genes Dev</source><year>2007</year><volume>21</volume><fpage>1882</fpage><lpage>1894</lpage><pub-id pub-id-type="pmid">17652178</pub-id></mixed-citation></ref><ref id="CR49"><label>49.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Moffatt</surname><given-names>P</given-names></name><name><surname>Gaumond</surname><given-names>M-H</given-names></name><name><surname>Salois</surname><given-names>P</given-names></name><name><surname>Sellin</surname><given-names>K</given-names></name><name><surname>Bessette</surname><given-names>M-C</given-names></name><name><surname>Godin</surname><given-names>E</given-names></name><name><surname>Oliveira</surname><given-names>PT</given-names></name><name><surname>Atkins</surname><given-names>GJ</given-names></name><name><surname>Nanci</surname><given-names>A</given-names></name><name><surname>Thomas</surname><given-names>G</given-names></name></person-group><article-title>Bril: A novel bone-specific modulator of mineralization</article-title><source>J Bone Mineral Res</source><year>2008</year><volume>23</volume><fpage>1497</fpage><lpage>1508</lpage></mixed-citation></ref><ref id="CR50"><label>50.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Riemenschneider</surname><given-names>M</given-names></name><name><surname>Buschges</surname><given-names>R</given-names></name><name><surname>Wolter</surname><given-names>M</given-names></name><name><surname>Reifenberger</surname><given-names>J</given-names></name><name><surname>Bostrom</surname><given-names>J</given-names></name><name><surname>Kraus</surname><given-names>JA</given-names></name><name><surname>Schlegel</surname><given-names>U</given-names></name><name><surname>Reifenberger</surname><given-names>G</given-names></name></person-group><article-title>Amplification and overexpression of the <italic>MDM4 (MDMX)</italic> gene from 1q32 in a subset of malignant gliomas without <italic>TP53</italic> mutation or <italic>MDM2</italic> amplification</article-title><source>Cancer Res</source><year>1999</year><volume>59</volume><fpage>6091</fpage><lpage>6096</lpage><pub-id pub-id-type="pmid">10626796</pub-id></mixed-citation></ref><ref id="CR51"><label>51.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lowenstein</surname><given-names>EJ</given-names></name><name><surname>Daly</surname><given-names>RJ</given-names></name><name><surname>Batzer</surname><given-names>AG</given-names></name><name><surname>Li</surname><given-names>W</given-names></name><name><surname>Margolis</surname><given-names>B</given-names></name><name><surname>Lammers</surname><given-names>R</given-names></name><name><surname>Ullrich</surname><given-names>A</given-names></name><name><surname>Skolnik</surname><given-names>EY</given-names></name><name><surname>Bar-Sagi</surname><given-names>D</given-names></name><name><surname>Schlessinger</surname><given-names>J</given-names></name></person-group><article-title>The SH2 and SH3 domain-containing protein GRB2 links receptor tyrosine kinases to ras signaling</article-title><source>Cell</source><year>1992</year><volume>70</volume><fpage>431</fpage><lpage>442</lpage><pub-id pub-id-type="pmid">1322798</pub-id></mixed-citation></ref><ref id="CR52"><label>52.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Geiss-Friedlander</surname><given-names>R</given-names></name><name><surname>Melchior</surname><given-names>F</given-names></name></person-group><article-title>Concepts in sumoylation: a decade on</article-title><source>Nat Rev Mol Cell Biol</source><year>2007</year><volume>8</volume><fpage>947</fpage><lpage>956</lpage><pub-id pub-id-type="pmid">18000527</pub-id></mixed-citation></ref><ref id="CR53"><label>53.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ulrich</surname><given-names>HD</given-names></name><name><surname>Walden</surname><given-names>H</given-names></name></person-group><article-title>Ubiquitin signaling in DNA replication and repair</article-title><source>Nat Rev Mol Cell Biol</source><year>2010</year><volume>11</volume><fpage>479</fpage><lpage>489</lpage><pub-id pub-id-type="pmid">20551964</pub-id></mixed-citation></ref><ref id="CR54"><label>54.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>MacDonald</surname><given-names>G</given-names></name><name><surname>Stramwasser</surname><given-names>M</given-names></name><name><surname>Mueller</surname><given-names>CR</given-names></name></person-group><article-title>Characterization of a negative transcription element in the <italic>BRCA1</italic> promoter</article-title><source>Breast Cancer Res</source><year>2007</year><volume>9</volume><fpage>R49</fpage><pub-id pub-id-type="pmid">17663789</pub-id></mixed-citation></ref><ref id="CR55"><label>55.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Baker</surname><given-names>KM</given-names></name><name><surname>Wei</surname><given-names>G</given-names></name><name><surname>Schaffner</surname><given-names>AE</given-names></name><name><surname>Ostrowski</surname><given-names>MC</given-names></name></person-group><article-title>Ets-2 and components of mammalian SWI/SNF form a repressor complex that negatively regulates the <italic>BRCA1</italic> promoter</article-title><source>J Biol Chem</source><year>2003</year><volume>278</volume><fpage>17876</fpage><lpage>17884</lpage><pub-id pub-id-type="pmid">12637547</pub-id></mixed-citation></ref><ref id="CR56"><label>56.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Huen</surname><given-names>MSY</given-names></name><name><surname>Sy</surname><given-names>SMH</given-names></name><name><surname>Chen</surname><given-names>J</given-names></name></person-group><article-title>BRCA1 and its toolbox for the maintenance of genome integrity</article-title><source>Nat Rev Mol Cell Biol</source><year>2010</year><volume>11</volume><fpage>138</fpage><lpage>148</lpage><pub-id pub-id-type="pmid">20029420</pub-id></mixed-citation></ref><ref id="CR57"><label>57.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Morris</surname><given-names>JR</given-names></name><name><surname>Boutell</surname><given-names>C</given-names></name><name><surname>Keppler</surname><given-names>M</given-names></name><name><surname>Densham</surname><given-names>R</given-names></name><name><surname>Weekes</surname><given-names>D</given-names></name><name><surname>Alamshah</surname><given-names>A</given-names></name><name><surname>Butler</surname><given-names>L</given-names></name><name><surname>Galanty</surname><given-names>Y</given-names></name><name><surname>Pangon</surname><given-names>L</given-names></name><name><surname>Kiuchi</surname><given-names>T</given-names></name><name><surname>Ng</surname><given-names>T</given-names></name><name><surname>Solomon</surname><given-names>E</given-names></name></person-group><article-title>The SUMO modification pathway is involved in the BRCA1 response to genotoxic stress</article-title><source>Nature</source><year>2009</year><volume>462</volume><fpage>886</fpage><lpage>890</lpage><pub-id pub-id-type="pmid">20016594</pub-id></mixed-citation></ref><ref id="CR58"><label>58.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Alpi</surname><given-names>AF</given-names></name><name><surname>Patel</surname><given-names>KJ</given-names></name></person-group><article-title>Monoubiquitylation in the Fanconi anaemia DNA damage response pathway</article-title><source>DNA Repair</source><year>2009</year><volume>8</volume><fpage>430</fpage><lpage>435</lpage><pub-id pub-id-type="pmid">19264559</pub-id></mixed-citation></ref><ref id="CR59"><label>59.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nakada</surname><given-names>S</given-names></name><name><surname>Tai</surname><given-names>I</given-names></name><name><surname>Panier</surname><given-names>S</given-names></name><name><surname>Al-Hakim</surname><given-names>A</given-names></name><name><surname>Iemura</surname><given-names>S</given-names></name><name><surname>Juang</surname><given-names>Y-C</given-names></name><name><surname>O&#x02019;Donnell</surname><given-names>L</given-names></name><name><surname>Kumakubo</surname><given-names>A</given-names></name><name><surname>Munro</surname><given-names>M</given-names></name><name><surname>Sicheri</surname><given-names>F</given-names></name><name><surname>Gingras</surname><given-names>A-C</given-names></name><name><surname>Natsume</surname><given-names>T</given-names></name><name><surname>Suda</surname><given-names>T</given-names></name><name><surname>Durocher</surname><given-names>D</given-names></name></person-group><article-title>Non-canonical inhibition of DNA damage-dependent ubiquitination by OTUB1</article-title><source>Nature</source><year>2010</year><volume>466</volume><fpage>941</fpage><lpage>946</lpage><pub-id pub-id-type="pmid">20725033</pub-id></mixed-citation></ref><ref id="CR60"><label>60.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lee</surname><given-names>NK</given-names></name><name><surname>Lee</surname><given-names>SY</given-names></name></person-group><article-title>Modulation of life and death by the tumor necrosis factor receptor-associated factors (TRAFs)</article-title><source>J Biochem Mol Biol</source><year>2002</year><volume>35</volume><fpage>61</fpage><lpage>66</lpage><pub-id pub-id-type="pmid">16248971</pub-id></mixed-citation></ref><ref id="CR61"><label>61.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fortin</surname><given-names>SP</given-names></name><name><surname>Ennis</surname><given-names>MJ</given-names></name><name><surname>Savitch</surname><given-names>BA</given-names></name><name><surname>Carpentieri</surname><given-names>D</given-names></name><name><surname>McDonough</surname><given-names>WS</given-names></name><name><surname>Winkles</surname><given-names>JA</given-names></name><name><surname>Loftus</surname><given-names>JC</given-names></name><name><surname>Kingsley</surname><given-names>C</given-names></name><name><surname>Hostetter</surname><given-names>G</given-names></name><name><surname>Tran</surname><given-names>NL</given-names></name></person-group><article-title>Tumor necrosis factor-like weak inducer of apoptosis stimulation of glioma cell survival is dependent on Akt2 function</article-title><source>Mol Cancer Res</source><year>2009</year><volume>7</volume><fpage>1871</fpage><lpage>1881</lpage><pub-id pub-id-type="pmid">19861406</pub-id></mixed-citation></ref><ref id="CR62"><label>62.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Petty</surname><given-names>RD</given-names></name><name><surname>Samuel</surname><given-names>LM</given-names></name><name><surname>Murray</surname><given-names>GI</given-names></name><name><surname>MacDonald</surname><given-names>G</given-names></name><name><surname>O&#x02019;Kelly</surname><given-names>T</given-names></name><name><surname>Loudon</surname><given-names>M</given-names></name><name><surname>Binnie</surname><given-names>N</given-names></name><name><surname>Aly</surname><given-names>E</given-names></name><name><surname>McKinlay</surname><given-names>A</given-names></name><name><surname>Wang</surname><given-names>W</given-names></name><name><surname>Gilbert</surname><given-names>F</given-names></name><name><surname>Semple</surname><given-names>S</given-names></name><name><surname>Collie-Duguid</surname><given-names>ESR</given-names></name></person-group><article-title>APRIL is a novel clinical chemo-resistance biomarker in colorectal adenocarcinoma identified by gene expression profiling</article-title><source>BMC Cancer</source><year>2009</year><volume>9</volume><fpage>434</fpage><pub-id pub-id-type="pmid">20003335</pub-id></mixed-citation></ref><ref id="CR63"><label>63.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Steer</surname><given-names>JH</given-names></name><name><surname>Kroeger</surname><given-names>KM</given-names></name><name><surname>Abraham</surname><given-names>LJ</given-names></name><name><surname>Joyce</surname><given-names>DA</given-names></name></person-group><article-title>Glucocorticoids suppress tumor necrosis factor-&#x003b1; expression by human monocytic THP-1 cells by suppressing transactivation through adjacent NF-&#x003ba;B and c-Jun-activating transcription factor-2 binding sites in the promoter</article-title><source>J Biol Chem</source><year>2000</year><volume>275</volume><fpage>18432</fpage><lpage>18440</lpage><pub-id pub-id-type="pmid">10748079</pub-id></mixed-citation></ref><ref id="CR64"><label>64.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Amir-Ahmady</surname><given-names>B</given-names></name><name><surname>Salati</surname><given-names>LM</given-names></name></person-group><article-title>Regulation of the processing of glucose-6-phosphate dehydrogenase mRNA by nutritional status</article-title><source>J Biol Chem</source><year>2001</year><volume>276</volume><fpage>10514</fpage><lpage>10523</lpage><pub-id pub-id-type="pmid">11124967</pub-id></mixed-citation></ref><ref id="CR65"><label>65.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Irimia</surname><given-names>JM</given-names></name><name><surname>Meyer</surname><given-names>CM</given-names></name><name><surname>Peper</surname><given-names>CL</given-names></name><name><surname>Zhai</surname><given-names>L</given-names></name><name><surname>Bock</surname><given-names>CB</given-names></name><name><surname>Previs</surname><given-names>SF</given-names></name><name><surname>McGuinness</surname><given-names>OP</given-names></name><name><surname>DePaoli-Roach</surname><given-names>A</given-names></name><name><surname>Roach</surname><given-names>PJ</given-names></name></person-group><article-title>Impaired glucose tolerance and predisposition to the fasted state in liver glycogen synthase knockout mice</article-title><source>J Biol Chem</source><year>2010</year><volume>285</volume><fpage>12851</fpage><lpage>12861</lpage><pub-id pub-id-type="pmid">20178984</pub-id></mixed-citation></ref><ref id="CR66"><label>66.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Di Daniel</surname><given-names>E</given-names></name><name><surname>Mok</surname><given-names>MHS</given-names></name><name><surname>Mead</surname><given-names>E</given-names></name><name><surname>Mutinelli</surname><given-names>C</given-names></name><name><surname>Zambello</surname><given-names>E</given-names></name><name><surname>Caberlotto</surname><given-names>LL</given-names></name><name><surname>Pell</surname><given-names>TJ</given-names></name><name><surname>Langmead</surname><given-names>CJ</given-names></name><name><surname>Shah</surname><given-names>AJ</given-names></name><name><surname>Duddy</surname><given-names>G</given-names></name><name><surname>Kew</surname><given-names>JNC</given-names></name><name><surname>Maycox</surname><given-names>PR</given-names></name></person-group><article-title>Evaluation of expression and function of the H<sup>+</sup>/<italic>myo</italic>-inositol transporter HMIT</article-title><source>BMC Cell Biol</source><year>2009</year><volume>10</volume><fpage>54</fpage><pub-id pub-id-type="pmid">19607714</pub-id></mixed-citation></ref><ref id="CR67"><label>67.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nilsson</surname><given-names>M</given-names></name><name><surname>Dahlman-Wright</surname><given-names>K</given-names></name><name><surname>Karelmo</surname><given-names>C</given-names></name><name><surname>Gustafsson</surname><given-names>J</given-names></name><name><surname>Steffensen</surname><given-names>KR</given-names></name></person-group><article-title>Elk1 and SRF transcription factors convey basal transcription and mediate glucose response via their binding sites in the human LXRB gene promoter</article-title><source>Nucleic Acids Res</source><year>2007</year><volume>35</volume><fpage>4858</fpage><lpage>4868</lpage><pub-id pub-id-type="pmid">17626048</pub-id></mixed-citation></ref><ref id="CR68"><label>68.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Faulkner</surname><given-names>NE</given-names></name><name><surname>Hilfinger</surname><given-names>JM</given-names></name><name><surname>Markovitz</surname><given-names>DM</given-names></name></person-group><article-title>Protein phosphatase 2A activates the HIV-2 promoter through enhancer elements that include the pets site</article-title><source>J Biol Chem</source><year>2001</year><volume>276</volume><fpage>25804</fpage><lpage>25812</lpage><pub-id pub-id-type="pmid">11320078</pub-id></mixed-citation></ref><ref id="CR69"><label>69.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Juang</surname><given-names>Y-T</given-names></name><name><surname>Sumibcay</surname><given-names>L</given-names></name><name><surname>Tolnay</surname><given-names>M</given-names></name><name><surname>Wang</surname><given-names>Y</given-names></name><name><surname>Kyttaris</surname><given-names>VC</given-names></name><name><surname>Tsokos</surname><given-names>GC</given-names></name></person-group><article-title>Elf-1 binds to GGAA elements on the FcR&#x003b3; promoter and represses its expression</article-title><source>J Immunol</source><year>2007</year><volume>179</volume><fpage>4884</fpage><lpage>4889</lpage><pub-id pub-id-type="pmid">17878388</pub-id></mixed-citation></ref><ref id="CR70"><label>70.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sementchenko</surname><given-names>VI</given-names></name><name><surname>Watson</surname><given-names>DK</given-names></name></person-group><article-title>Ets target genes: past, present and future</article-title><source>Oncogene</source><year>2000</year><volume>19</volume><fpage>6533</fpage><lpage>6548</lpage><pub-id pub-id-type="pmid">11175369</pub-id></mixed-citation></ref><ref id="CR71"><label>71.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bina</surname><given-names>M</given-names></name><name><surname>Wyss</surname><given-names>P</given-names></name><name><surname>Ren</surname><given-names>W</given-names></name><name><surname>Szpankowski</surname><given-names>W</given-names></name><name><surname>Thomas</surname><given-names>E</given-names></name><name><surname>Randhawa</surname><given-names>R</given-names></name><name><surname>Reddy</surname><given-names>S</given-names></name><name><surname>John</surname><given-names>PM</given-names></name><name><surname>Pares-Matos</surname><given-names>EI</given-names></name><name><surname>Stein</surname><given-names>A</given-names></name><name><surname>Xu</surname><given-names>H</given-names></name><name><surname>Lazarus</surname><given-names>SA</given-names></name></person-group><article-title>Exploring the characteristics of sequence elements in proximal promoters of human genes</article-title><source>Genomics</source><year>2004</year><volume>84</volume><fpage>929</fpage><lpage>940</lpage><pub-id pub-id-type="pmid">15533710</pub-id></mixed-citation></ref><ref id="CR72"><label>72.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>FitzGerald</surname><given-names>PC</given-names></name><name><surname>Shlyakhtenko</surname><given-names>A</given-names></name><name><surname>Mir</surname><given-names>AA</given-names></name><name><surname>Vinson</surname><given-names>C</given-names></name></person-group><article-title>Clustering of DNA sequences in human promoters</article-title><source>Genome Res</source><year>2004</year><volume>14</volume><fpage>1562</fpage><lpage>1574</lpage><pub-id pub-id-type="pmid">15256515</pub-id></mixed-citation></ref><ref id="CR73"><label>73.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Xie</surname><given-names>X</given-names></name><name><surname>Lu</surname><given-names>J</given-names></name><name><surname>Kulbokas</surname><given-names>EJ</given-names></name><name><surname>Golub</surname><given-names>TR</given-names></name><name><surname>Mootha</surname><given-names>V</given-names></name><name><surname>Lindblad-Toh</surname><given-names>K</given-names></name><name><surname>Lander</surname><given-names>ES</given-names></name><name><surname>Kellis</surname><given-names>M</given-names></name></person-group><article-title>Systematic discovery of regulatory motifs in human promoters and 3&#x02032; UTRs by comparison of several mammals</article-title><source>Nature</source><year>2005</year><volume>434</volume><fpage>338</fpage><lpage>345</lpage><pub-id pub-id-type="pmid">15735639</pub-id></mixed-citation></ref><ref id="CR74"><label>74.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wei</surname><given-names>GH</given-names></name><name><surname>Badis</surname><given-names>G</given-names></name><name><surname>Berger</surname><given-names>MF</given-names></name><name><surname>Kivioja</surname><given-names>T</given-names></name><name><surname>Palin</surname><given-names>K</given-names></name><name><surname>Enge</surname><given-names>M</given-names></name><name><surname>Bonke</surname><given-names>M</given-names></name><name><surname>Jolma</surname><given-names>A</given-names></name><name><surname>Varjosalo</surname><given-names>M</given-names></name><name><surname>Gehrke</surname><given-names>AR</given-names></name><name><surname>Yan</surname><given-names>J</given-names></name><name><surname>Talukder</surname><given-names>S</given-names></name><name><surname>Turunen</surname><given-names>M</given-names></name><name><surname>Taipale</surname><given-names>M</given-names></name><name><surname>Stunnenberg</surname><given-names>HG</given-names></name><name><surname>Ukkonen</surname><given-names>E</given-names></name><name><surname>Hughes</surname><given-names>TR</given-names></name><name><surname>Bulyk</surname><given-names>ML</given-names></name><name><surname>Taipale</surname><given-names>J</given-names></name></person-group><article-title>Genome-wide analysis of ETS-family DNA-binding in vitro and in vivo</article-title><source>EMBO J</source><year>2010</year><volume>29</volume><fpage>2147</fpage><lpage>2160</lpage><pub-id pub-id-type="pmid">20517297</pub-id></mixed-citation></ref><ref id="CR75"><label>75.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Oikawa</surname><given-names>T</given-names></name><name><surname>Yamada</surname><given-names>T</given-names></name></person-group><article-title>Molecular biology of the Ets family of transcription factors</article-title><source>Gene</source><year>2003</year><volume>303</volume><fpage>11</fpage><lpage>34</lpage><pub-id pub-id-type="pmid">12559563</pub-id></mixed-citation></ref><ref id="CR76"><label>76.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hsu</surname><given-names>T</given-names></name><name><surname>Trojanowska</surname><given-names>M</given-names></name><name><surname>Watson</surname><given-names>DK</given-names></name></person-group><article-title>Ets proteins in biological control and cancer</article-title><source>J Cell Biochem</source><year>2004</year><volume>91</volume><fpage>896</fpage><lpage>903</lpage><pub-id pub-id-type="pmid">15034925</pub-id></mixed-citation></ref><ref id="CR77"><label>77.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bartel</surname><given-names>FO</given-names></name><name><surname>Higuchi</surname><given-names>T</given-names></name><name><surname>Spyropoulos</surname><given-names>DD</given-names></name></person-group><article-title>Mouse models in the study of the Ets family of transcription factors</article-title><source>Oncogene</source><year>2000</year><volume>19</volume><fpage>6443</fpage><lpage>6454</lpage><pub-id pub-id-type="pmid">11175360</pub-id></mixed-citation></ref><ref id="CR78"><label>78.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dwyer</surname><given-names>J</given-names></name><name><surname>Li</surname><given-names>H</given-names></name><name><surname>Xu</surname><given-names>D</given-names></name><name><surname>Liu</surname><given-names>JP</given-names></name></person-group><article-title>Transcriptional regulation of telomerase activity: roles of the Ets transcription factor family</article-title><source>Ann N Y Acad Sci</source><year>2007</year><volume>1114</volume><fpage>36</fpage><lpage>47</lpage><pub-id pub-id-type="pmid">17986575</pub-id></mixed-citation></ref><ref id="CR79"><label>79.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Goueli</surname><given-names>BS</given-names></name><name><surname>Janknecht</surname><given-names>R</given-names></name></person-group><article-title>Upregulation of the catalytic telomerase subunit by the transcription factor ER81 and oncogenic HER2/Neu, Ras, or Raf</article-title><source>Mol Cell Biol</source><year>2004</year><volume>24</volume><fpage>25</fpage><lpage>35</lpage><pub-id pub-id-type="pmid">14673140</pub-id></mixed-citation></ref><ref id="CR80"><label>80.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Xu</surname><given-names>D</given-names></name><name><surname>Dwyer</surname><given-names>J</given-names></name><name><surname>Li</surname><given-names>H</given-names></name><name><surname>Duan</surname><given-names>W</given-names></name><name><surname>Liu</surname><given-names>JP</given-names></name></person-group><article-title>Ets2 maintains hTERT gene expression and breast cancer cell proliferation by interacting with c-Myc</article-title><source>J Biol Chem</source><year>2008</year><volume>283</volume><fpage>23567</fpage><lpage>23580</lpage><pub-id pub-id-type="pmid">18586674</pub-id></mixed-citation></ref><ref id="CR81"><label>81.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hsu</surname><given-names>CP</given-names></name><name><surname>Hsu</surname><given-names>NY</given-names></name><name><surname>Lee</surname><given-names>LW</given-names></name><name><surname>Ko</surname><given-names>JL</given-names></name></person-group><article-title>Ets2 binding site single nucleotide polymorphism at the hTERT gene promoter-effect on telomerase expression and telomerase length maintenance in non-small cell lung cancer</article-title><source>Eur J Cancer</source><year>2006</year><volume>42</volume><fpage>1466</fpage><lpage>1474</lpage><pub-id pub-id-type="pmid">16737810</pub-id></mixed-citation></ref><ref id="CR82"><label>82.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Baillat</surname><given-names>D</given-names></name><name><surname>Laitem</surname><given-names>C</given-names></name><name><surname>Leprivier</surname><given-names>G</given-names></name><name><surname>Margerin</surname><given-names>C</given-names></name><name><surname>Aumercier</surname><given-names>M</given-names></name></person-group><article-title>Ets-1 binds cooperatively to the palindromic Ets-binding sites in the p53 promoter</article-title><source>Biochem Biophys Res Commun</source><year>2009</year><volume>378</volume><fpage>213</fpage><lpage>217</lpage><pub-id pub-id-type="pmid">19022222</pub-id></mixed-citation></ref><ref id="CR83"><label>83.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Xu</surname><given-names>D</given-names></name><name><surname>Watson</surname><given-names>TJ</given-names></name><name><surname>Chan</surname><given-names>D</given-names></name><name><surname>Luca</surname><given-names>E</given-names></name><name><surname>Zhou</surname><given-names>J</given-names></name><name><surname>Herzog</surname><given-names>PJ</given-names></name><name><surname>Kola</surname><given-names>I</given-names></name></person-group><article-title>Ets1 is required for p53 transcriptional activity in UV-induced apoptosis in embryonic stem cells</article-title><source>EMBO J</source><year>2002</year><volume>21</volume><fpage>4081</fpage><lpage>4093</lpage><pub-id pub-id-type="pmid">12145208</pub-id></mixed-citation></ref><ref id="CR84"><label>84.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kawase</surname><given-names>T</given-names></name><name><surname>Ichikawa</surname><given-names>H</given-names></name><name><surname>Ohta</surname><given-names>T</given-names></name><name><surname>Nozaki</surname><given-names>N</given-names></name><name><surname>Tashiro</surname><given-names>F</given-names></name><name><surname>Ohki</surname><given-names>R</given-names></name><name><surname>Taya</surname><given-names>Y</given-names></name></person-group><article-title>p53 target gene <italic>AEN</italic> is a nuclear exonuclease required for p53-dependent apoptosis</article-title><source>Oncogene</source><year>2008</year><volume>27</volume><fpage>3797</fpage><lpage>3810</lpage><pub-id pub-id-type="pmid">18264133</pub-id></mixed-citation></ref><ref id="CR85"><label>85.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Burch</surname><given-names>LR</given-names></name><name><surname>Scotto</surname><given-names>M</given-names></name><name><surname>Pohler</surname><given-names>E</given-names></name><name><surname>Meek</surname><given-names>D</given-names></name><name><surname>Hupp</surname><given-names>T</given-names></name></person-group><article-title>Phage-peptide display identifies the interferon-responsive, death-activated protein kinase family as a novel modifier of MDM2 and p21<sup>WAF1</sup></article-title><source>J Mol Biol</source><year>2004</year><volume>337</volume><fpage>115</fpage><lpage>128</lpage><pub-id pub-id-type="pmid">15001356</pub-id></mixed-citation></ref><ref id="CR86"><label>86.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bosman</surname><given-names>JD</given-names></name><name><surname>Yehiely</surname><given-names>F</given-names></name><name><surname>Evans</surname><given-names>JR</given-names></name><name><surname>Cryns</surname><given-names>VL</given-names></name></person-group><article-title>Regulation of alphaB-crystallin gene expression by the transcription factor Ets1 in breast cancer</article-title><source>Breast Cancer Res Treat</source><year>2010</year><volume>119</volume><fpage>63</fpage><lpage>70</lpage><pub-id pub-id-type="pmid">19205872</pub-id></mixed-citation></ref><ref id="CR87"><label>87.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Prescott</surname><given-names>JD</given-names></name><name><surname>Koto</surname><given-names>KS</given-names></name><name><surname>Singh</surname><given-names>M</given-names></name><name><surname>Gutierrez-Hartmann</surname><given-names>A</given-names></name></person-group><article-title>The ETS transcription factor ESE-1 transforms MCF-12A human mammary epithelial cells via a novel cytoplasmic mechanism</article-title><source>Mol Cell Biol</source><year>2004</year><volume>24</volume><fpage>5548</fpage><lpage>5564</lpage><pub-id pub-id-type="pmid">15169914</pub-id></mixed-citation></ref><ref id="CR88"><label>88.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chi</surname><given-names>P</given-names></name><name><surname>Chen</surname><given-names>Y</given-names></name><name><surname>Zhang</surname><given-names>L</given-names></name><name><surname>Guo</surname><given-names>X</given-names></name><name><surname>Wongvipat</surname><given-names>J</given-names></name><name><surname>Shamu</surname><given-names>T</given-names></name><name><surname>Fletcher</surname><given-names>JA</given-names></name><name><surname>Dewell</surname><given-names>S</given-names></name><name><surname>Maki</surname><given-names>RG</given-names></name><name><surname>Zheng</surname><given-names>D</given-names></name><name><surname>Antonescu</surname><given-names>CR</given-names></name><name><surname>Allis</surname><given-names>CD</given-names></name><name><surname>Sawyers</surname><given-names>CL</given-names></name></person-group><article-title>ETV1 is a lineage survival factor that cooperates with KIT in gastrointestinal stromal tumours</article-title><source>Nature</source><year>2010</year><volume>467</volume><fpage>849</fpage><lpage>853</lpage><pub-id pub-id-type="pmid">20927104</pub-id></mixed-citation></ref><ref id="CR89"><label>89.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Berger</surname><given-names>MF</given-names></name><name><surname>Lawrence</surname><given-names>MS</given-names></name><name><surname>Demichelis</surname><given-names>F</given-names></name><name><surname>Drier</surname><given-names>Y</given-names></name><name><surname>Cibulskis</surname><given-names>K</given-names></name><name><surname>Sivachenko</surname><given-names>AY</given-names></name><name><surname>Sboner</surname><given-names>A</given-names></name><name><surname>Esgueva</surname><given-names>R</given-names></name><name><surname>Pflueger</surname><given-names>D</given-names></name><name><surname>Sougnez</surname><given-names>C</given-names></name><name><surname>Onofrio</surname><given-names>R</given-names></name><name><surname>Carter</surname><given-names>SL</given-names></name><name><surname>Park</surname><given-names>K</given-names></name><name><surname>Habegger</surname><given-names>L</given-names></name><name><surname>Ambrogio</surname><given-names>L</given-names></name><name><surname>Fennell</surname><given-names>T</given-names></name><name><surname>Parkin</surname><given-names>M</given-names></name><name><surname>Saksena</surname><given-names>G</given-names></name><name><surname>Voet</surname><given-names>D</given-names></name><name><surname>Ramos</surname><given-names>AH</given-names></name><name><surname>Pugh</surname><given-names>TJ</given-names></name><name><surname>Wilkinson</surname><given-names>J</given-names></name><name><surname>Fisher</surname><given-names>S</given-names></name><name><surname>Winckler</surname><given-names>W</given-names></name><name><surname>Mahan</surname><given-names>S</given-names></name><name><surname>Ardlie</surname><given-names>K</given-names></name><name><surname>Baldwin</surname><given-names>J</given-names></name><name><surname>Simons</surname><given-names>JW</given-names></name><name><surname>Kitabayashi</surname><given-names>N</given-names></name><name><surname>MacDonald</surname><given-names>TY</given-names></name><name><surname>Kantoff</surname><given-names>PW</given-names></name><name><surname>Chin</surname><given-names>L</given-names></name><name><surname>Gabriel</surname><given-names>SB</given-names></name><name><surname>Gerstein</surname><given-names>MB</given-names></name><name><surname>Golub</surname><given-names>TR</given-names></name><name><surname>Meyerson</surname><given-names>M</given-names></name><name><surname>Tewari</surname><given-names>A</given-names></name><name><surname>Lander</surname><given-names>ES</given-names></name><name><surname>Getz</surname><given-names>G</given-names></name><name><surname>Rubin</surname><given-names>MA</given-names></name><name><surname>Garraway</surname><given-names>LA</given-names></name></person-group><article-title>The genomic complexity of primary human prostate cancer</article-title><source>Nature</source><year>2011</year><volume>470</volume><fpage>214</fpage><lpage>220</lpage><pub-id pub-id-type="pmid">21307934</pub-id></mixed-citation></ref><ref id="CR90"><label>90.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Soldatenkov</surname><given-names>VA</given-names></name><name><surname>Albor</surname><given-names>A</given-names></name><name><surname>Patel</surname><given-names>BK</given-names></name><name><surname>Dreszer</surname><given-names>R</given-names></name><name><surname>Dritschilo</surname><given-names>A</given-names></name><name><surname>Notario</surname><given-names>V</given-names></name></person-group><article-title>Regulation of the human poly(ADP-ribose) polymerase promoter by the ETS transcription factor</article-title><source>Oncogene</source><year>1999</year><volume>18</volume><fpage>3954</fpage><lpage>3962</lpage><pub-id pub-id-type="pmid">10435618</pub-id></mixed-citation></ref><ref id="CR91"><label>91.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Park</surname><given-names>JS</given-names></name><name><surname>Qiao</surname><given-names>L</given-names></name><name><surname>Gilfor</surname><given-names>D</given-names></name><name><surname>Yang</surname><given-names>MY</given-names></name><name><surname>Hylemon</surname><given-names>PB</given-names></name><name><surname>Benz</surname><given-names>C</given-names></name><name><surname>Darlington</surname><given-names>G</given-names></name><name><surname>Firestone</surname><given-names>G</given-names></name><name><surname>Fisher</surname><given-names>PB</given-names></name><name><surname>Dent</surname><given-names>P</given-names></name></person-group><article-title>A role both Ets and C/EBP transcription factors and mRNA stabilization in the MAPK-dependent increase in p21<sup>Cip&#x02212;1/WAF1/mda6</sup> protein levels in primary hepatocytes</article-title><source>Mol Biol Cell</source><year>2000</year><volume>11</volume><fpage>2915</fpage><lpage>2932</lpage><pub-id pub-id-type="pmid">10982390</pub-id></mixed-citation></ref><ref id="CR92"><label>92.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhivotovsky</surname><given-names>B</given-names></name><name><surname>Orrenius</surname><given-names>S</given-names></name></person-group><article-title>Cell death mechanisms: cross-talk and role in disease</article-title><source>Exp Cell Res</source><year>2010</year><volume>316</volume><fpage>1374</fpage><lpage>1383</lpage><pub-id pub-id-type="pmid">20211164</pub-id></mixed-citation></ref><ref id="CR93"><label>93.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Li</surname><given-names>P</given-names></name><name><surname>Allen</surname><given-names>H</given-names></name><name><surname>Banerjee</surname><given-names>S</given-names></name><name><surname>Franklin</surname><given-names>S</given-names></name><name><surname>Herzog</surname><given-names>L</given-names></name><name><surname>Johnston</surname><given-names>C</given-names></name><name><surname>McDowell</surname><given-names>J</given-names></name><name><surname>Paskind</surname><given-names>M</given-names></name><name><surname>Rodman</surname><given-names>L</given-names></name><name><surname>Salfeld</surname><given-names>J</given-names></name><name><surname>Towne</surname><given-names>E</given-names></name><name><surname>Tracey</surname><given-names>D</given-names></name><name><surname>Wardwell</surname><given-names>S</given-names></name><name><surname>Wei</surname><given-names>F-Y</given-names></name><name><surname>Wong</surname><given-names>W</given-names></name><name><surname>Kamen</surname><given-names>R</given-names></name><name><surname>Seshadri</surname><given-names>T</given-names></name></person-group><article-title>Mice deficient in IL-1&#x003b2;-converting enzyme are defective in production of mature IL-1&#x003b2; and resistant to endotoxic shock</article-title><source>Cell</source><year>1995</year><volume>80</volume><fpage>401</fpage><lpage>411</lpage><pub-id pub-id-type="pmid">7859282</pub-id></mixed-citation></ref><ref id="CR94"><label>94.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kuida</surname><given-names>K</given-names></name><name><surname>Lippke</surname><given-names>JA</given-names></name><name><surname>Ku</surname><given-names>G</given-names></name><name><surname>Harding</surname><given-names>MW</given-names></name><name><surname>Livingston</surname><given-names>DJ</given-names></name><name><surname>Su</surname><given-names>MS-S</given-names></name><name><surname>Flavell</surname><given-names>RA</given-names></name></person-group><article-title>Altered cytokine export and apoptosis in mice deficient in interleukin-1 beta converting enzyme</article-title><source>Science</source><year>1995</year><volume>267</volume><fpage>2000</fpage><lpage>2003</lpage><pub-id pub-id-type="pmid">7535475</pub-id></mixed-citation></ref><ref id="CR95"><label>95.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Miura</surname><given-names>M</given-names></name><name><surname>Zhou</surname><given-names>H</given-names></name><name><surname>Rotello</surname><given-names>R</given-names></name><name><surname>Hartwieg</surname><given-names>EA</given-names></name><name><surname>Yuan</surname><given-names>Y</given-names></name></person-group><article-title>Induction of apoptosis in fibroblasts by IL-1&#x003b2; -converting enzyme, a mammalian homolog of the <italic>C. elegans</italic> cell death gene ced-3</article-title><source>Cell</source><year>1993</year><volume>75</volume><fpage>653</fpage><lpage>660</lpage><pub-id pub-id-type="pmid">8242741</pub-id></mixed-citation></ref><ref id="CR96"><label>96.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kondo</surname><given-names>S</given-names></name><name><surname>Barna</surname><given-names>BP</given-names></name><name><surname>Morimura</surname><given-names>T</given-names></name><name><surname>Takeuchi</surname><given-names>J</given-names></name><name><surname>Yuan</surname><given-names>J</given-names></name><name><surname>Akbasak</surname><given-names>A</given-names></name><name><surname>Barnett</surname><given-names>GH</given-names></name></person-group><article-title>Interleukin-1 &#x003b2;-converting enzyme mediates cisplatin-induced apoptosis in malignant glioma cells</article-title><source>Cancer Res</source><year>1995</year><volume>55</volume><fpage>6166</fpage><lpage>6171</lpage><pub-id pub-id-type="pmid">8521409</pub-id></mixed-citation></ref><ref id="CR97"><label>97.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pei</surname><given-names>H</given-names></name><name><surname>Li</surname><given-names>C</given-names></name><name><surname>Adereth</surname><given-names>Y</given-names></name><name><surname>Hsu</surname><given-names>T</given-names></name><name><surname>Watson</surname><given-names>DK</given-names></name><name><surname>Li</surname><given-names>R</given-names></name></person-group><article-title>Caspase-1 is a direct target gene of ETS1 and plays a role in ETS1-induced apoptosis</article-title><source>Cancer Res</source><year>2005</year><volume>65</volume><fpage>7205</fpage><lpage>7213</lpage><pub-id pub-id-type="pmid">16103071</pub-id></mixed-citation></ref><ref id="CR98"><label>98.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kihara-Negishi</surname><given-names>F</given-names></name><name><surname>Yamada</surname><given-names>T</given-names></name><name><surname>Kubota</surname><given-names>Y</given-names></name><name><surname>Kondoh</surname><given-names>N</given-names></name><name><surname>Yamamoto</surname><given-names>H</given-names></name><name><surname>Abe</surname><given-names>M</given-names></name><name><surname>Shirai</surname><given-names>T</given-names></name><name><surname>Hashimoto</surname><given-names>Y</given-names></name><name><surname>Oikawa</surname><given-names>T</given-names></name></person-group><article-title>Down-regulation of c-myc and bcl-2 gene expression in PU.1-induced apoptosis in murine erythroleukemia cells</article-title><source>Int J Cancer</source><year>1998</year><volume>76</volume><fpage>523</fpage><lpage>530</lpage><pub-id pub-id-type="pmid">9590129</pub-id></mixed-citation></ref><ref id="CR99"><label>99.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Oikawa</surname><given-names>T</given-names></name><name><surname>Yamada</surname><given-names>T</given-names></name><name><surname>Kihara-Negishi</surname><given-names>F</given-names></name><name><surname>Yamamoto</surname><given-names>H</given-names></name><name><surname>Kondoh</surname><given-names>N</given-names></name><name><surname>Hitomi</surname><given-names>Y</given-names></name><name><surname>Hashimoto</surname><given-names>Y</given-names></name></person-group><article-title>The role of Ets family transcription factor PU.1 in hematopoietic cell differentiation, proliferation and apoptosis</article-title><source>Cell Death Differ</source><year>1999</year><volume>6</volume><fpage>599</fpage><lpage>608</lpage><pub-id pub-id-type="pmid">10453070</pub-id></mixed-citation></ref><ref id="CR100"><label>100.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Birdsey</surname><given-names>GM</given-names></name><name><surname>Dryden</surname><given-names>NH</given-names></name><name><surname>Amsellem</surname><given-names>V</given-names></name><name><surname>Gebhardt</surname><given-names>F</given-names></name><name><surname>Sahnan</surname><given-names>K</given-names></name><name><surname>Haskard</surname><given-names>DO</given-names></name><name><surname>Dejana</surname><given-names>E</given-names></name><name><surname>Mason</surname><given-names>JC</given-names></name><name><surname>Randi</surname><given-names>AM</given-names></name></person-group><article-title>Transcription factor Erg regulates angiogenesis and endothelial apoptosis through VE-cadherin</article-title><source>Blood</source><year>2008</year><volume>111</volume><fpage>3498</fpage><lpage>3506</lpage><pub-id pub-id-type="pmid">18195090</pub-id></mixed-citation></ref><ref id="CR101"><label>101.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wei</surname><given-names>G</given-names></name><name><surname>Srinivasan</surname><given-names>R</given-names></name><name><surname>Cantemir-Stone</surname><given-names>CZ</given-names></name><name><surname>Sharma</surname><given-names>SM</given-names></name><name><surname>Santhanam</surname><given-names>R</given-names></name><name><surname>Weinstein</surname><given-names>M</given-names></name><name><surname>Muthusamy</surname><given-names>N</given-names></name><name><surname>Man</surname><given-names>AK</given-names></name><name><surname>Oshima</surname><given-names>RG</given-names></name><name><surname>Leone</surname><given-names>G</given-names></name><name><surname>Ostrowski</surname><given-names>MC</given-names></name></person-group><article-title><italic>Ets1</italic> and <italic>Ets2</italic> are required for endothelial cell survival during embryonic angiogenesis</article-title><source>Blood</source><year>2009</year><volume>114</volume><fpage>1123</fpage><lpage>1130</lpage><pub-id pub-id-type="pmid">19411629</pub-id></mixed-citation></ref><ref id="CR102"><label>102.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gory</surname><given-names>S</given-names></name><name><surname>Dalmon</surname><given-names>J</given-names></name><name><surname>Prandini</surname><given-names>M</given-names></name><name><surname>Kortulewski</surname><given-names>T</given-names></name><name><surname>Launoit</surname><given-names>Y</given-names></name><name><surname>Huber</surname><given-names>P</given-names></name></person-group><article-title>Requirement of a GT box (Sp1 site) and two Ets binding sites for vascular endothelial cadherin gene transcription</article-title><source>J Biol Chem</source><year>1998</year><volume>273</volume><fpage>6750</fpage><lpage>6755</lpage><pub-id pub-id-type="pmid">9506975</pub-id></mixed-citation></ref><ref id="CR103"><label>103.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cao</surname><given-names>X</given-names></name><name><surname>Littlejohn</surname><given-names>J</given-names></name><name><surname>Rodarte</surname><given-names>C</given-names></name><name><surname>Zhang</surname><given-names>L</given-names></name><name><surname>Martino</surname><given-names>B</given-names></name><name><surname>Rascoe</surname><given-names>P</given-names></name><name><surname>Hamid</surname><given-names>K</given-names></name><name><surname>Jupiter</surname><given-names>D</given-names></name><name><surname>Smythe</surname><given-names>WR</given-names></name></person-group><article-title>Up-regulation of Bcl-xl by hepatocyte growth factor in human mesothelioma cells involves ETS transcription factors</article-title><source>Am J Pathol</source><year>2009</year><volume>175</volume><fpage>2207</fpage><lpage>2216</lpage><pub-id pub-id-type="pmid">19834061</pub-id></mixed-citation></ref><ref id="CR104"><label>104.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hashiguchi</surname><given-names>K</given-names></name><name><surname>Tsuchiya</surname><given-names>H</given-names></name><name><surname>Tomita</surname><given-names>A</given-names></name><name><surname>Ueda</surname><given-names>C</given-names></name><name><surname>Akechi</surname><given-names>Y</given-names></name><name><surname>Sakabe</surname><given-names>T</given-names></name><name><surname>Kurimasa</surname><given-names>A</given-names></name><name><surname>Nozaki</surname><given-names>M</given-names></name><name><surname>Yamada</surname><given-names>T</given-names></name><name><surname>Tsuchida</surname><given-names>S</given-names></name><name><surname>Shiota</surname><given-names>G</given-names></name></person-group><article-title>Involvement of ETS1 in thioredoxin-binding protein 2 transcription induced by a synthetic retinoid CD437 in human osteosarcoma cells</article-title><source>Biochem Biophys Res Commun</source><year>2010</year><volume>391</volume><fpage>621</fpage><lpage>626</lpage><pub-id pub-id-type="pmid">19932085</pub-id></mixed-citation></ref><ref id="CR105"><label>105.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Matsuoka</surname><given-names>S</given-names></name><name><surname>Tsuchiya</surname><given-names>H</given-names></name><name><surname>Sakabe</surname><given-names>T</given-names></name><name><surname>Watanabe</surname><given-names>Y</given-names></name><name><surname>Hoshikawa</surname><given-names>Y</given-names></name><name><surname>Kurimasa</surname><given-names>A</given-names></name><name><surname>Itamochi</surname><given-names>H</given-names></name><name><surname>Harada</surname><given-names>T</given-names></name><name><surname>Terakawa</surname><given-names>N</given-names></name><name><surname>Masutani</surname><given-names>H</given-names></name><name><surname>Yodoi</surname><given-names>J</given-names></name><name><surname>Shiota</surname><given-names>G</given-names></name></person-group><article-title>Involvement of thioredoxin-binding protein 2 in the antitumor activity of CD437</article-title><source>Cancer Sci</source><year>2008</year><volume>99</volume><fpage>2485</fpage><lpage>2490</lpage><pub-id pub-id-type="pmid">19018770</pub-id></mixed-citation></ref><ref id="CR106"><label>106.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Li</surname><given-names>YY</given-names></name><name><surname>Wu</surname><given-names>Y</given-names></name><name><surname>Tsuneyama</surname><given-names>K</given-names></name><name><surname>Baba</surname><given-names>T</given-names></name><name><surname>Mukaida</surname><given-names>N</given-names></name></person-group><article-title>Essential contribution of Ets-1 to constitutive Pim-3 expression in human pancreatic cancer cells</article-title><source>Cancer Sci</source><year>2009</year><volume>100</volume><fpage>396</fpage><lpage>404</lpage><pub-id pub-id-type="pmid">19154409</pub-id></mixed-citation></ref><ref id="CR107"><label>107.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Omata</surname><given-names>K</given-names></name><name><surname>Suzuki</surname><given-names>R</given-names></name><name><surname>Masaki</surname><given-names>T</given-names></name><name><surname>Miyamura</surname><given-names>T</given-names></name><name><surname>Satoh</surname><given-names>T</given-names></name><name><surname>Suzuki</surname><given-names>T</given-names></name></person-group><article-title>Identification and characterization of the human inhibitor of caspase-activated DNase gene promoter</article-title><source>Apoptosis</source><year>2008</year><volume>13</volume><fpage>929</fpage><lpage>937</lpage><pub-id pub-id-type="pmid">18500556</pub-id></mixed-citation></ref><ref id="CR108"><label>108.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Frampton</surname><given-names>J</given-names></name><name><surname>Ramqvist</surname><given-names>T</given-names></name><name><surname>Graf</surname><given-names>T</given-names></name></person-group><article-title>v-Myb of E26 leukemia virus up-regulates bcl-2 and suppresses apoptosis in myeloid cells</article-title><source>Genes Dev</source><year>1996</year><volume>10</volume><fpage>2720</fpage><lpage>2731</lpage><pub-id pub-id-type="pmid">8946913</pub-id></mixed-citation></ref><ref id="CR109"><label>109.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Li</surname><given-names>XR</given-names></name><name><surname>Chong</surname><given-names>AS</given-names></name><name><surname>Wu</surname><given-names>J</given-names></name><name><surname>Roebuck</surname><given-names>KA</given-names></name><name><surname>Kumar</surname><given-names>A</given-names></name><name><surname>Parrillo</surname><given-names>JE</given-names></name><name><surname>Rapp</surname><given-names>UR</given-names></name><name><surname>Kimberly</surname><given-names>RP</given-names></name><name><surname>Williams</surname><given-names>JW</given-names></name><name><surname>Xu</surname><given-names>X</given-names></name></person-group><article-title>Transcriptional regulation of Fas gene expression by GA-binding protein and AP-1 in T cell antigen receptor-CD3 complex-stimulated T cells</article-title><source>J Biol Chem</source><year>1999</year><volume>274</volume><fpage>35203</fpage><lpage>35210</lpage><pub-id pub-id-type="pmid">10575005</pub-id></mixed-citation></ref><ref id="CR110"><label>110.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chow</surname><given-names>W</given-names></name><name><surname>Fang</surname><given-names>J</given-names></name><name><surname>Yee</surname><given-names>J</given-names></name></person-group><article-title>The IFN regulatory factor family participates in regulation of Fas ligand gene expression in T cells</article-title><source>J Immunol</source><year>2000</year><volume>164</volume><fpage>3512</fpage><lpage>3518</lpage><pub-id pub-id-type="pmid">10725705</pub-id></mixed-citation></ref><ref id="CR111"><label>111.</label><mixed-citation publication-type="other">Carey MF, Peterson CL, Smale ST (2009) Transcription and preinitiation complex assembly in vitro. In: Transcriptional regulation in eukaryotes, 2nd edn. Cold Spring Harbor Laboratory Press, Cold Spring Harbor, pp 439&#x02013;538</mixed-citation></ref><ref id="CR112"><label>112.</label><mixed-citation publication-type="other">Turner BM (2001) Transcription in eukaryotes: The problems of complexity. In: Chromatin and gene regulation: mechanisms in epigenetics. Blackwell, Oxford, pp 25&#x02013;43</mixed-citation></ref><ref id="CR113"><label>113.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yang</surname><given-names>C</given-names></name><name><surname>Bolotin</surname><given-names>E</given-names></name><name><surname>Jiang</surname><given-names>T</given-names></name><name><surname>Sladek</surname><given-names>FM</given-names></name><name><surname>Martinez</surname><given-names>E</given-names></name></person-group><article-title>Prevalence of the initiator over the TATA box in human and yeast genes and identification of DNA motifs enriched in human TATA-less core promoters</article-title><source>Gene</source><year>2007</year><volume>389</volume><fpage>52</fpage><lpage>65</lpage><pub-id pub-id-type="pmid">17123746</pub-id></mixed-citation></ref><ref id="CR114"><label>114.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Foulds</surname><given-names>CE</given-names></name><name><surname>Hawley</surname><given-names>DK</given-names></name></person-group><article-title>Analysis of the human TATA binding protein promoter and identification of an ets site critical for activity</article-title><source>Nucleic Acids Res</source><year>1997</year><volume>25</volume><fpage>2485</fpage><lpage>2494</lpage><pub-id pub-id-type="pmid">9171103</pub-id></mixed-citation></ref><ref id="CR115"><label>115.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Boros</surname><given-names>J</given-names></name><name><surname>Donaldson</surname><given-names>IJ</given-names></name><name><surname>O&#x02019;Donnell</surname><given-names>A</given-names></name><name><surname>Odrowaz</surname><given-names>ZA</given-names></name><name><surname>Zeef</surname><given-names>L</given-names></name><name><surname>Lupien</surname><given-names>M</given-names></name><name><surname>Meyer</surname><given-names>CA</given-names></name><name><surname>Shirley Liu</surname><given-names>X</given-names></name><name><surname>Brown</surname><given-names>M</given-names></name></person-group><article-title>Elucidation of the ELK1 target gene network reveals a role in the coordinate regulation of core components of the gene regulation machinery</article-title><source>Genome Res</source><year>2009</year><volume>19</volume><fpage>1963</fpage><lpage>1973</lpage><pub-id pub-id-type="pmid">19687146</pub-id></mixed-citation></ref><ref id="CR116"><label>116.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chang</surname><given-names>CH</given-names></name><name><surname>Scott</surname><given-names>GK</given-names></name><name><surname>Baldwin</surname><given-names>MA</given-names></name><name><surname>Benz</surname><given-names>CC</given-names></name></person-group><article-title>Exon 4-encoded acidic domain in the epithelium-restricted Ets factor, ESX, confers potent transactivating capacity and binds to TATA-binding protein (TBP)</article-title><source>Oncogene</source><year>1999</year><volume>18</volume><fpage>3682</fpage><lpage>3695</lpage><pub-id pub-id-type="pmid">10391676</pub-id></mixed-citation></ref><ref id="CR117"><label>117.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Defossez</surname><given-names>PA</given-names></name><name><surname>Baert</surname><given-names>JL</given-names></name><name><surname>Monnot</surname><given-names>M</given-names></name><name><surname>Launoit</surname><given-names>Y</given-names></name></person-group><article-title>The ETS family member ERM contains an &#x003b1;-helical acidic activation domain that contacts TAFII60</article-title><source>Nucleic Acids Res</source><year>1997</year><volume>25</volume><fpage>4455</fpage><lpage>4463</lpage><pub-id pub-id-type="pmid">9358152</pub-id></mixed-citation></ref><ref id="CR118"><label>118.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yaneva</surname><given-names>M</given-names></name><name><surname>Kippenberger</surname><given-names>S</given-names></name><name><surname>Wang</surname><given-names>N</given-names></name><name><surname>Su</surname><given-names>Q</given-names></name><name><surname>McGarvey</surname><given-names>M</given-names></name><name><surname>Nazarian</surname><given-names>A</given-names></name><name><surname>Lacomis</surname><given-names>L</given-names></name><name><surname>Erdjument-Bromage</surname><given-names>H</given-names></name><name><surname>Tempst</surname><given-names>P</given-names></name></person-group><article-title>PU.1 and a TTTAAA element in the myeloid <italic>Defensin-1</italic> promoter create an operational TATA box that can impose cell specificity onto TFIID function</article-title><source>J Immunol</source><year>2006</year><volume>176</volume><fpage>6906</fpage><lpage>6917</lpage><pub-id pub-id-type="pmid">16709851</pub-id></mixed-citation></ref><ref id="CR119"><label>119.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Agarkar</surname><given-names>VB</given-names></name><name><surname>Babayeva</surname><given-names>ND</given-names></name><name><surname>Wilder</surname><given-names>PJ</given-names></name><name><surname>Rizzino</surname><given-names>A</given-names></name><name><surname>Tahirov</surname><given-names>TH</given-names></name></person-group><article-title>Crystal structure of mouse Elf3 C-terminal DNA-binding domain in complex with type II TGF-&#x003b2; receptor promoter DNA</article-title><source>J Mol Biol</source><year>2010</year><volume>397</volume><fpage>278</fpage><lpage>289</lpage><pub-id pub-id-type="pmid">20079749</pub-id></mixed-citation></ref><ref id="CR120"><label>120.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Marecki</surname><given-names>S</given-names></name><name><surname>Riendeau</surname><given-names>CJ</given-names></name><name><surname>Liang</surname><given-names>MD</given-names></name><name><surname>Fenton</surname><given-names>MJ</given-names></name></person-group><article-title>PU.1 and multiple IFN regulatory factor proteins synergize to mediate transcriptional activation of the human IL-1&#x003b2; gene</article-title><source>J Immunol</source><year>2001</year><volume>166</volume><fpage>6829</fpage><lpage>6838</lpage><pub-id pub-id-type="pmid">11359842</pub-id></mixed-citation></ref><ref id="CR121"><label>121.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wieratra</surname><given-names>I</given-names></name></person-group><article-title>Sp1: Emerging roles-beyond constitutive activation of TATA-less housekeeping genes</article-title><source>Biochem Biophys Res Commun</source><year>2008</year><volume>372</volume><fpage>1</fpage><lpage>13</lpage><pub-id pub-id-type="pmid">18364237</pub-id></mixed-citation></ref><ref id="CR122"><label>122.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pastorcic</surname><given-names>M</given-names></name><name><surname>Das</surname><given-names>HK</given-names></name></person-group><article-title>Alternative initiation of transcription of the human presenilin 1 gene in SH-SY5Y and SK-N-SH cells</article-title><source>Eur J Biochem</source><year>2004</year><volume>271</volume><fpage>4485</fpage><lpage>4494</lpage><pub-id pub-id-type="pmid">15560789</pub-id></mixed-citation></ref><ref id="CR123"><label>123.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kumar</surname><given-names>P</given-names></name><name><surname>Garg</surname><given-names>R</given-names></name><name><surname>Bolden</surname><given-names>G</given-names></name><name><surname>Pandey</surname><given-names>KN</given-names></name></person-group><article-title>Interactive roles of Ets-1, Sp1, and acetylated histones in the retinoic acid-dependent activation of guanylyl cyclase/atrial natriuretic peptide receptor-A gene transcription</article-title><source>J Biol Chem</source><year>2010</year><volume>285</volume><fpage>37521</fpage><lpage>37530</lpage><pub-id pub-id-type="pmid">20864529</pub-id></mixed-citation></ref><ref id="CR124"><label>124.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jiang</surname><given-names>P</given-names></name><name><surname>Kumar</surname><given-names>A</given-names></name><name><surname>Parrillo</surname><given-names>JE</given-names></name><name><surname>Dempsey</surname><given-names>LA</given-names></name><name><surname>Platt</surname><given-names>JL</given-names></name><name><surname>Prinz</surname><given-names>RA</given-names></name><name><surname>Xu</surname><given-names>X</given-names></name></person-group><article-title>Cloning and characterization of the human heparanase-1 (<italic>HPR1</italic>) gene promoter: role of GA-binding protein and Sp1 in regulating HPR1 basal promoter activity</article-title><source>J Biol Chem</source><year>2002</year><volume>277</volume><fpage>8989</fpage><lpage>8998</lpage><pub-id pub-id-type="pmid">11779847</pub-id></mixed-citation></ref><ref id="CR125"><label>125.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sturm</surname><given-names>RA</given-names></name><name><surname>Cassady</surname><given-names>JL</given-names></name><name><surname>Das</surname><given-names>G</given-names></name><name><surname>Romo</surname><given-names>A</given-names></name><name><surname>Evans</surname><given-names>GA</given-names></name></person-group><article-title>Chromosomal structure and expression of the human OTF1 locus encoding the Oct-1 protein</article-title><source>Genomics</source><year>1993</year><volume>16</volume><fpage>333</fpage><lpage>341</lpage><pub-id pub-id-type="pmid">8314572</pub-id></mixed-citation></ref><ref id="CR126"><label>126.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kemler</surname><given-names>I</given-names></name><name><surname>Schaffner</surname><given-names>W</given-names></name></person-group><article-title>Octamer transfaction factors and the cell type-specificity of immunoglobulin gene expression</article-title><source>FASEB J</source><year>1990</year><volume>4</volume><fpage>1444</fpage><lpage>1449</lpage><pub-id pub-id-type="pmid">2407588</pub-id></mixed-citation></ref><ref id="CR127"><label>127.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kwon</surname><given-names>UK</given-names></name><name><surname>Yen</surname><given-names>PH</given-names></name><name><surname>Collins</surname><given-names>T</given-names></name><name><surname>Wells</surname><given-names>RA</given-names></name></person-group><article-title>Differential lineage-specific regulation of murine CD45 transcription by Oct-1 and PU.1</article-title><source>Biochem Biopys Res Commun</source><year>2006</year><volume>344</volume><fpage>146</fpage><lpage>154</lpage></mixed-citation></ref><ref id="CR128"><label>128.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Liu</surname><given-names>M</given-names></name><name><surname>Leibowitz</surname><given-names>JL</given-names></name><name><surname>Clark</surname><given-names>DA</given-names></name><name><surname>Mendicino</surname><given-names>M</given-names></name><name><surname>Ning</surname><given-names>Q</given-names></name><name><surname>Ding</surname><given-names>JW</given-names></name><name><surname>D&#x02019;Abreo</surname><given-names>C</given-names></name><name><surname>Fung</surname><given-names>L</given-names></name><name><surname>Marsden</surname><given-names>PA</given-names></name><name><surname>Levy</surname><given-names>GA</given-names></name></person-group><article-title>Gene transcription of fgl2 in epithelial cells is controlled by Ets-1 and Oct-1 and requires the presence of both Sp1 and Sp3</article-title><source>Eur J Biochem</source><year>2003</year><volume>270</volume><fpage>2274</fpage><lpage>2286</lpage><pub-id pub-id-type="pmid">12752447</pub-id></mixed-citation></ref><ref id="CR129"><label>129.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Liu</surname><given-names>M</given-names></name><name><surname>Mendicino</surname><given-names>M</given-names></name><name><surname>Ning</surname><given-names>Q</given-names></name><name><surname>Ghanekar</surname><given-names>A</given-names></name><name><surname>He</surname><given-names>W</given-names></name><name><surname>McGilvray</surname><given-names>I</given-names></name><name><surname>Shalev</surname><given-names>I</given-names></name><name><surname>Clark</surname><given-names>DA</given-names></name><name><surname>Phillips MJ</surname><given-names>GA</given-names></name><name><surname>Levy</surname><given-names>GA</given-names></name></person-group><article-title>Cytokine-induced hepatic apoptosis is dependent on FGL2/fibroleukin: the role of Sp1/Sp3 and STAT1/PU.1 composite <italic>cis</italic> elements</article-title><source>J Immunol</source><year>2006</year><volume>176</volume><fpage>7028</fpage><lpage>7038</lpage><pub-id pub-id-type="pmid">16709865</pub-id></mixed-citation></ref><ref id="CR130"><label>130.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Muller</surname><given-names>S</given-names></name><name><surname>Maas</surname><given-names>A</given-names></name><name><surname>Islam</surname><given-names>TC</given-names></name><name><surname>Sideras</surname><given-names>P</given-names></name><name><surname>Suske</surname><given-names>G</given-names></name><name><surname>Philipsen</surname><given-names>S</given-names></name><name><surname>Xanthopoulos</surname><given-names>KG</given-names></name><name><surname>Hendriks</surname><given-names>RW</given-names></name><name><surname>Smith</surname><given-names>CIE</given-names></name></person-group><article-title>Synergistic activation of the human Btk promoter by transcription factors Sp1/3 and PU.1</article-title><source>Biochem Biopys Res Commun</source><year>1999</year><volume>259</volume><fpage>364</fpage><lpage>369</lpage></mixed-citation></ref><ref id="CR131"><label>131.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Brunner</surname><given-names>C</given-names></name><name><surname>Wirth</surname><given-names>T</given-names></name></person-group><article-title>Btk expression is controlled by Oct and BOB.1/OBF.1</article-title><source>Nucleic Acids Res</source><year>2006</year><volume>34</volume><fpage>1807</fpage><lpage>1815</lpage><pub-id pub-id-type="pmid">16582106</pub-id></mixed-citation></ref><ref id="CR132"><label>132.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bradford</surname><given-names>AP</given-names></name><name><surname>Conrad</surname><given-names>KE</given-names></name><name><surname>Wasylyk</surname><given-names>C</given-names></name><name><surname>Wasylyk</surname><given-names>B</given-names></name><name><surname>Gutierrez-Hartmann</surname><given-names>A</given-names></name></person-group><article-title>Functional interaction of c-Ets-1 and GHF-1/Pit-1 mediates Ras activation of pituitary-specific gene expression: mapping of the essential c-Ets-1 domain</article-title><source>Mol Cell Biol</source><year>1995</year><volume>15</volume><fpage>2849</fpage><lpage>2857</lpage><pub-id pub-id-type="pmid">7739565</pub-id></mixed-citation></ref><ref id="CR133"><label>133.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Turner</surname><given-names>EC</given-names></name><name><surname>Kinsella</surname><given-names>BT</given-names></name></person-group><article-title>Transcriptional regulation of the human prostacyclin receptor gene is dependent on Sp1, PU.1 and Oct-1 in megakaryocytes and endothelial cells</article-title><source>J Mol Biol</source><year>2009</year><volume>386</volume><fpage>579</fpage><lpage>597</lpage><pub-id pub-id-type="pmid">19118563</pub-id></mixed-citation></ref><ref id="CR134"><label>134.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hollenhorst</surname><given-names>PC</given-names></name><name><surname>Chandler</surname><given-names>KJ</given-names></name><name><surname>Poulsen</surname><given-names>RL</given-names></name><name><surname>Johnson</surname><given-names>WE</given-names></name><name><surname>Speck</surname><given-names>NA</given-names></name><name><surname>Graves</surname><given-names>BJ</given-names></name></person-group><article-title>DNA specificity determinants associate with distinct transcription factor functions</article-title><source>PLoS Genet</source><year>2009</year><volume>5</volume><fpage>e1000778</fpage><pub-id pub-id-type="pmid">20019798</pub-id></mixed-citation></ref><ref id="CR135"><label>135.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Oikawa</surname><given-names>T</given-names></name></person-group><article-title>ETS transcription factors: possible targets for cancer therapy</article-title><source>Cancer Sci</source><year>2003</year><volume>95</volume><fpage>626</fpage><lpage>633</lpage><pub-id pub-id-type="pmid">15298723</pub-id></mixed-citation></ref></ref-list><glossary><title>Abbreviations</title><def-list><def-list><def-item><term>ATRA</term><def><p>All-<italic>trans</italic> retinoic acid</p></def></def-item><def-item><term>bp</term><def><p>Base pair</p></def></def-item><def-item><term>IFN</term><def><p>Interferon</p></def></def-item><def-item><term>iPS cells</term><def><p>Induced pluripotent stem cells</p></def></def-item><def-item><term>ISRE</term><def><p>Interferon-stimulated response element</p></def></def-item><def-item><term>Luc</term><def><p>Luciferase</p></def></def-item><def-item><term>MCS</term><def><p>Multi-cloning site</p></def></def-item><def-item><term>nt</term><def><p>Nucleotide(s)</p></def></def-item><def-item><term>PARG</term><def><p>Poly(ADP-ribose) glycohydrolase</p></def></def-item><def-item><term>PD-1</term><def><p>Programmed death-1</p></def></def-item><def-item><term>TBP</term><def><p>TATA-binding protein</p></def></def-item><def-item><term>TPA</term><def><p>12-<italic>O</italic>-tetradecanoyl-phorbol-13-acetate</p></def></def-item><def-item><term>TSS</term><def><p>Transcription start site</p></def></def-item></def-list></def-list></glossary></back></article>